Home
  >  
Section 32

EurekaMag Full Text Articles Chapter 31,994



References:

Hooghe Peters E.L.; Velkeniers B.; Vanhaelst L.; Hooghe R. 1991: Interleukin 1 interleukin 6 messengers in the neuroendocrine immune system?. Pathology Research and Practice 187(5): 622-625
Graham, M.F.; Bryson, G.R.; Diegelmann, R.F. 1989: Interleukin 1 is a mitogen for and selectively augments collagen production by human intestinal smooth muscle hism cells. Gastroenterology 96(5 Part 2): A181
Mertz, P.M.; Davis, S.C.; Eaglstein, W.H.; Kilian, P.; Sauder, D.N. 1989: Interleukin 1 is a potent inducer of wound reepithelialization. Clinical Research 37(2): 677A
Mazer, C.D.; Freedman, J.; Hayward, C. 1990: Interleukin 1 levels during and after normothermic cardiopulmonary bypass. Anesthesiology 73(3A): A155
Granholm, K.; Soder, O. 1989: Interleukin 1 like growth factors in normal tissues in the rat. Acta Paediatrica Scandinavica Suppl (359): 7
D.C.nha A.; Fauci, A.S.; Vitkovic, L. 1990: Interleukin 1 mediated stimulation of transforming growth factor beta in astrocytes. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract 1106
Fujii, A.; Matsumoto, H. 1992: Interleukin 1 might be a co factor for gingival overgrowth by nifedipine. Journal of Dental Research 71(Special Issue): 624
Schettini, G.; Florio, T.; Meucci, O.; Landolfi, E.; Grimaldi, M.; Ventra, C.; Marino, A. 1990: Interleukin 1 modulation of anterior pituitary function effects on prolactin release and postreceptor transducing mechanisms. O'dorisio, M S And A Panerai (Ed ) Annals Of The New York Academy Of Sciences, Vol 594 Neuropeptides And Immunopeptides: Messengers in A Neuroimmune Axis; Conference, New York, New York, Usa, October 2-4, 1989 Xv+503p New York Academy Of Sciences: New York, New York, Usa Illus 489-491
Larsen, C.G.; Oppenheim, J.J.; Matsushima, K. 1989: Interleukin 1 or tumor necrosis factor stimulate the production of neutrophil activating protein by normal human fibroblasts and keratinocytes. Clinical Research 37(2): 692A
Rogers, H.; Sheehan, K.C.F.; Brunt, M.; Dower, S.; Unanue, E.R.; Schreiber, R.D. 1992: Interleukin 1 participates in the early stages of protection against listeria monocytogenes. FASEB Journal 6(4): A1123
Kim, T-Jong.; Kim, T-Hwan.; Lee, H-Joo.; Peddle, L.; Rahman, P.; Hu, P.; Greenwood, C.M.T.; Inman, R.D. 2008: Interleukin 1 polymorphisms in patients with ankylosing spondylitis in Korea. Journal of Rheumatology 35(8): 1603-1608
Fagarasan, M.O.; Rinaudo, M.S.; Bishop, J.F.; Axelrod, J. 1989: Interleukin 1 potentiates the secretion of beta endorphin induced by secretagogues via protein kinases in a mouse pituitary cell line att 20. Society for Neuroscience Abstracts 15(1): 7
Moreno S.; Stefanini S.; Di Biagio P.; Hassan G. 1991: Interleukin 1 producing plasma cells in chronic active liver diseases and in kidney and liver grafts. European Journal of Cell Biology Suppl (35): 49
Furusawa, S.; Kawa, Y.; Takahama, H.; Okitsu, S.; Onishi, T.; Matsuo, M.; Mizoguchi, M. 1989: Interleukin 1 production by epidermal cells in contact hypersensitivity. Clinical Research 37(2): 751A
Roberge C.J.; Grassi J.; De Medicis R.; Naccache P.H.; Poubelle P.E. 1991: Interleukin 1 production by normal human blood neutrophils in response to phagocytosis receptor dependent and receptor independent agonists. Clinical and Investigative Medicine 14(4 Suppl): A117
Simbirtseva, N.Y.; Konusova, V.G.; Simbirtsev, A.S.; Ketlinsky, S.A.; Almazov, V.A. 1991: Interleukin 1 production in patients with acute leukemia and myelodysplastic syndrome. European Journal of Cancer 27(Suppl 3): S87
Lee C Y.; White, J.E.; Tsan M F. 1991: Interleukin 1 protects against oxygen induced pulmonary injury. Laboratory Investigation 64(1): 116A
Cominelli, F.; Nast, C.C.; Towner, J.; Zipser, R.D.; Dinarello, C.A. 1989: Interleukin 1 protects rabbits from induced colitis role of endogenous prostaglandins. Gastroenterology 96(5 Part 2): A96
Mizutari, S.; Sato, H.; Horio, S.; Hisayama, T.; Moritoki, H. 1997: Interleukin 1 receptor activation is involved in iNOS mRNA production and its degradation in vascular smooth muscle cells. Japanese Journal of Pharmacology 75(Suppl 1): 70P
Brett, P.M.; Herbst, F.; Yasuda, N.; Yiannakou, J.Y.; Nicholls, R.J.; Ciclitira, P.J. 1996: Interleukin 1 receptor antagonist VNTR polymorphism and pouchitis. Clinical Science (London) 90(2): 9P
Arend, W.P. 1991: Interleukin 1 receptor antagonist. A new member of the interleukin 1 family. Journal of Clinical Investigation 88(5): 1445-1451
Hannum, C.H.; Wilcox, C.J.; Arend, W.P.; Joslin, F.G.; Dripps, D.J.; Heimdal, P.L.; Armes, L.G.; Sommer, A.; Eisenberg, S.P.; Thompson, R.C. 1990: Interleukin 1 receptor antagonist activity of a human interleukin 1 inhibitor. Nature (London) 343(6256): 336-340
Pereira, B.J.G.; King, A.J.; Poutsiaka, D.D.; Strom, J.A.; Narayan, G.; Levey, A.S.; Dinarello, C.A. 1992: Interleukin 1 receptor antagonist an index of dialysis induced cytokine production. Journal of the American Society of Nephrology 3(3): 387
Aiura, K.; Gelfand, J.A.; Wakabayashi, G.; Callahan, M.V.; Burke, J.F.; Thompson, R.C.; Dinarello, C.A. 1991: Interleukin 1 receptor antagonist blocks hypotension in a rabbit model of gram positive septic shock. Cytokine 3(5): 498
Granowitz E.V.; Porat R.; Mier J.W.; Orencole S.F.; Callahan M.V.; Cannon J.G.; Lynch E.A.; Ye K.; Poutsiaka D.D.; Et Al 1992: Interleukin 1 receptor antagonist blocks the neutrophilia and immunosuppressive effects of experimental endotoxemia. Clinical Research 40(3): 651A
Zumsteg, U.; Helqvist, S.; Pociot, F.; Nerup, J. 1991: Interleukin 1 receptor antagonist does not counteract effects of interleukin 1 on rodent beta cell function. Diabetologia 34(Suppl 2): A95
Mcintyre, K.W.; Stepan, G.; Kolinsky, K.; Benjamin, W.R.; Hageman, R.; Thompson, R.C.; Kilian, P.L. 1990: Interleukin 1 receptor antagonist il 1ra blocks acute inflammatory responses to il 1 and other agents in vivo. FASEB Journal 4(7): A2062
Poutsiaka, D.D.; Goldman, B.D.; Koh, H.K.; Dinarello, C.A. 1991: Interleukin 1 receptor antagonist il 1ra but not il 1 beta is produced by human peripheral blood leukocytes pbl after photopheresis. Cytokine 3(5): 502
Poutsiaka D.D.; Vannier E.; Ye K.; Dinarello C.A. 1991: Interleukin 1 receptor antagonist il 1ra gene expression in lipopolysaccharide lps stimulated human peripheral blood mononuclear cells pbmc. Cytokine 3(5): 502
Marsh, C.B.; Wewers, M.D. 1992: Interleukin 1 receptor antagonist il 1ra inhibits lipopolysaccharide lps induced monocyte interleukin 1 beta il 1 beta and tumor necrosis factor alpha tnfalpha production. Clinical Research 40(2): 327A
Murthy, S.; Cooper, H.; Coppola, D.; Shirer, R. 1992: Interleukin 1 receptor antagonist il 1ra is effective against dextran sulfate dss mediated colitis in mice. Gastroenterology 102(4 Part 2): A669
Mancini, R.; Jezequel, A.M.; Marucci, L.; Orlandi, F. 1992: Interleukin 1 receptor antagonist il 1ra reduces collagen deposition in experimental hepatic fibrosis. Journal of Hepatology 16(Suppl 1): S32
Witkin, S.S.; Gravett, M.G.; Haluska, G.J.; Jeremias, J.; Novy, M.J. 1993: Interleukin 1 receptor antagonist in the fetal circulation and in amniotic fluid after experimental intra-AF infection of rhesus monkeys. Journal of Immunology 150(8 Part 2): 201A
Cozzolino, F.; Torcia, M.; Lucicibello, M.; Fabiani, S.; Bettoni, S.; Crescioli, C.; Dinanarello, C.A.; Rambaldi, A. 1991: Interleukin 1 receptor antagonist inhibits acute myeloid leukemia cell growth in vitro. Journal of Cellular Biochemistry Suppl (15 Part G): 17
Granowitz, E.V.; Clark, B.D.; Vannier, E.; Callahan, M.V.; Dinarello, C.A. 1991: Interleukin 1 receptor antagonist inhibits interleukin 1 induced cytokine synthesis by human monocytes. Clinical Research 39(2): 462A
Relton, J.K.; Rothwell, N.J. 1992: Interleukin 1 receptor antagonist inhibits ischaemic and excitotoxin brain damage in the rat. Journal of Physiology (Cambridge) 452: 122P
Granowitz, E.V.; Santos, A.; Poutsiaka, D.D.; Cannon, J.G.; Wilmore, D.W.; Wolff, S.M.; Dinarello, C.A. 1991: Interleukin 1 receptor antagonist production during experimental endotoxemia in healthy volunteers. Cytokine 3(5): 501
Kennedy, M.; Armstrong, C.A.; Rosenbaum, J.T.; Ansel, J.C. 1994: Interleukin 1 receptor antagonist production in human cornea. IOVS Investigative Ophthalmology and Visual Science 35(4): 1302
Matta, S.G.; Linner, K.M.; Sharp, B.M. 1991: Interleukin 1 receptor antagonist protein inhibits acth responses to interleukin 1 beta administered iv or into the median eminence of the rat. Clinical Research 39(2): 323A
Sim, T.C.; Hilsmeier, K.A.; Grant, J.A.; Lett Brown, M.A.; Alam, R. 1993: Interleukin 1 receptor antagonist protein inhibits the synthesis of histamine releasing factors by allergen-stimulated mononuclear cells. Journal of Immunology 150(8 Part 2): 65A
Chensue, S.W.; Kunkel, S.; Hershey, S.; Warmington, K.; Tracey, D.E. 1992: Interleukin 1 receptor antagonist protein irap abrogates foreign body but not hypersensitivity type granulomas. FASEB Journal 6(4): A1330
Mccurry, K.R.; Campbell, D.A.Jr; Tracey, D.E.; Howatt, M.A.; Remick, D.G. 1992: Interleukin 1 receptor antagonist protein irap does not prevent hepatic ischemia reperfusion induced injury. FASEB Journal 6(4): A1026
Matta, S.G.; Linner, K.M.; Sharp, B.M. 1991: Interleukin 1 receptor antagonist protein irap equally inhibits il 1 alpha and il 1 beta induced acth secretion and thymocyte proliferation. Society for Neuroscience Abstracts 17(1-2): 1196
Malak, T.A.; Deforge, L.E.; Tracey, D.E.; Kenney, J.S.; Remick, D.G. 1992: Interleukin 1 receptor antagonist protein irap inhibits interleukin 8 production. FASEB Journal 6(5): A1605
Berger, A.E.; Carter, D.B.; Hankey, S.O.; Mcewan, R.N. 1991: Interleukin 1 receptor antagonist protein irap messenger rna regulation in u937 cells. Journal of Cellular Biochemistry Suppl 15(Part E): 170
Ohlsson, K.; Bjork, P.; Bergenfeldt, M.; Hageman, R.; Thompson, R.C. 1990: Interleukin 1 receptor antagonist reduces mortality from endotoxin shock. Nature (London) 348(6301): 550-552
Aebischer, P.; Guenard, V.; Dinarello, C.A. 1991: Interleukin 1 receptor antagonist released from a polymeric guidance channel impedes peripheral nerve regeneration. Society for Neuroscience Abstracts 17(1-2): 1483
Rozycki, H.J.; Narimanbekov, I.O. 1992: Interleukin 1 receptor antagonist ril 1ra blocks the cellular inflammatory response to hyperoxia hyperventilation induced lung injury. Pediatric Research 31(4 Part 2): 321A
Yamada, J.; Dana, M.R.; Zhu, S.N.; Alard, P.; Streilein, J.W. 1998: Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation. Archives of Ophthalmology 116(10): 1351-1357
Wang, Z.; Buckingham, B.; Soon Shiong, P.; Heintz, R.; Varsanyi Nagy, M. 1992: Interleukin 1 receptor expression in human islets. Clinical Research 40(1): 34A
Haour, F.; Ban, E.; Marquette, C.; Rostene, W.; Fillion, G. 1993: Interleukin 1 receptor in nervous and neuroendocrine systems Modulation during infection and stress. Journal of Neurochemistry 61(Suppl ): S126
Dinarello, C.A.; Clark, B.D.; Ikejima, T.; Puren, A.J.; Savage, N.; Rosoff, P.M. 1990: Interleukin 1 receptors and biological responses. Yale Journal of Biology and Medicine 63(2): 87-93
Homo Delarche, F.; Amrani, A.; Tehrani, M.J.; Pleau, J.M.; Mormede, P.; Dardenne, M.; Haour, F. 1994: Interleukin 1 receptors are present and functional in the nonobese diabetic mouse at the prediabetic stage. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 146
D.S.uza E.B.; Takao, T.; Tracey, D.E. 1990: Interleukin 1 receptors in mouse brain. Neuroendocrinology 52(Suppl 1): 76
Takao T.; Tracey D.E.; Mitchell W.M.; De Souza E.B. 1990: Interleukin 1 receptors in mouse brain characterization and autoradiographic localization. Society for Neuroscience Abstracts 16(2): 1213
Joss, U.; Schmidli, I.; Ferralli, J.; Fournier, B. 1990: Interleukin 1 receptors in osteosarcoma cells mg63 prostaglandin induction at low receptor occupancy. Calcified Tissue International 46(Suppl 2): A36
Cunningham, E.T.; De Souza, E.B. 1993: Interleukin 1 receptors in the brain and endocrine tissues. Immunology Today 14(4): 171-176
Cronkhite, R.J.; Plate, J.M.D. 1990: Interleukin 1 receptors of epstein barr virus ebv transformed b cell lines demonstrate unique binding properties. Proceedings of the American Association for Cancer Research 31: 238
Rodan, S.B.; Chin, J.; Wesolowski, G.; Rodan, G.A.; Schmidt, J.A. 1989: Interleukin 1 receptors on a clonal human osteosarcoma cell like. Calcified Tissue International 44(Suppl): S44
Nagy, M.V.; Dadufalza, V.; Soon Shiong, P.; Heintz, R.; Buckingham, B. 1992: Interleukin 1 receptors on human and rat insulin producing beta cells. Clinical Research 40(2): 147A
Rinehart, C.A.; Vanle, L.; Haskill, J.S.; Kaufman, D.G. 1992: Interleukin 1 reduces lifespan in human endometrial stromal cells. Proceedings of the American Association for Cancer Research 33: 149
Schmiegel, W.; Roeder, C.; Humburg, I.; Thiele, H.G.; Greten, H.; Kalthoff, H. 1991: Interleukin 1 regulated cytokine expression in pancreatic cancer cells. Gastroenterology 100(5 Part 2): A665
Bird, T.A.; Davies, T.; Baldwin, S.A.; Saklatvala, J. 1990: Interleukin 1 regulates the glucose transporter of fibroblasts. Oppenheim, J J , Et Al (Ed ) Progress in Leukocyte Biology, Vol 10a Molecular And Cellular Biology Of Cytokines; Second International Workshop on Cytokines, Hilton Head Island, South Carolina, Usa, December 10-14, 1989 Xli+570p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 215-220
O'grady S.; Rutherford, R.B. 1989: Interleukin 1 regulation of fibroblast pge production. Journal of Dental Research 68(Special Issue): 932
Datta, S.; Engleman, R.M.; Low, H.; Preissler, P.; Allmendinger, P.; Takata, H.; Maulik, N.; Nath, D.; Das, D.K. 1991: Interleukin 1 regulation of hydroxyl radical production in patients undergoing cardiopulmonary bypass. Cytokine 3(5): 507
Kanosky, M.G.; Ellsaesser, C.; Das, S.K. 1991: Interleukin 1 response to injected silicone in a rat model. Clinical Research 39(2): 436A
Harms, B.; Lorenz, I.; Schneider, E.M. 1992: Interleukin 1 responsiveness determines senescence in hematopoietically active fibroblasts concomitantly with a diminution of adhesion molecules. Experimental Hematology (Charlottesville) 20(6): 814
Schimmel, R.J.; Mochan, E. 1991: Interleukin 1 selectively potentiates bradykinin stimulated arachidonic acid release in human synovial fibroblasts. Arthritis and Rheumatism 34(9 Suppl): S141
Fouladi-Nashta, A.A.; Mohamet, L.; Heath, J.K.; Kimber, S.J. 2008: Interleukin 1 signaling is regulated by leukemia inhibitory factor (LIF) and is aberrant in Lif-/- mouse uterus. Biology of Reproduction 79(1): 142-153
O'neill, L.A.J.; Matthews, J.S.; Palsson, E.; Jeffries, C.; Brennan, P.; Cantrell, D.A. 1997: Interleukin 1 signalling Synergy with Rac1 and P13 kinase and evidence for the involvement of a low-molecular weight G protein. Biochemical Society Transactions 25(4): S578
Buttle, D.J.; Saklatvala, J.; Barrett, A.J. 1991: Interleukin 1 stimulated cartilage proteoglycan degradation is inhibited by some cysteine endopeptidase inactivators. Cytokine 3(5): 499
Wardle, T.D.; Turnberg, L.A. 1992: Interleukin 1 stimulates chloride secretion in mammalian colon. Gastroenterology 102(4 Part 2): A252
Hanley, N.A.; Williams, B.C.; Bird, I.M.; Walker, S.W. 1991: Interleukin 1 stimulates growth of adrenocortical cells in primary culture. Journal of Endocrinology 129(Suppl): ABSTRACT 52
Carman Krzan, M.; Vige, X.; Wise, B.C. 1990: Interleukin 1 stimulates nerve growth factor ngf synthesis and secretion in primary cultures of rat astrocytes. FASEB Journal 4(4): A902
Kokia, E.; Hurwitz, A.; Ricciarelli, E.; Resnick, C.E.; Adashi, E.Y. 1992: Interleukin 1 stimulates ovarian prostaglandin biosynthesis obligatory role for heterologous contact independent cell cell interaction. Biology of Reproduction 46(Suppl 1): 91
Bomalaski, J.S.; Ford, T.A.; Simon, P.; Clark, M.A. 1992: Interleukin 1 stimulates phospholipase A-2 activating protein and PLAP stimulates interleukin 1 release Phospholipase-cytokine circuitry. Arthritis and Rheumatism 35(9 Suppl): S121
Bomalaski, J.S.; Ford, T.A.; Simon, P.; Clark, M.A. 1991: Interleukin 1 stimulates phospholipase a 2 activating protein plap and plap stimulates interleukin 1 release phospholipase cytokine circuitry. Arthritis and Rheumatism 34(9 Suppl): S47
Michel, J.B.; Quertermous, T. 1989: Interleukin 1 stimulates plasminogen activator and plasminogen activator inhibitor expression in human fibroblasts. Clinical Research 37(2): 558A
Varilek, G.W.; Bishop, W.P.; Neil, G.A. 1992: Interleukin 1 stimulates proliferation of the human intestinal epithelial cell line caco 2. Gastroenterology 102(4 Part 2): A583
Ascensao, J.L.; Klein, R.L.; Lopes Virella, M.F. 1989: Interleukin 1 stimulates the degradation of low density lipoprotein by human endothelial cells. Clinical Research 37(2): 404A
Chao, J.C.; Spilburg, C.A.; Welgus, H.G.; Jeffrey, J.J.; Schreiner, G.F.; Lange, L.G. 1990: Interleukin 1 stimulates the production of gelatinase from neonatal rat cardiac fibroblasts. Circulation 82(4 Suppl 3): III351
Kostiza, T.; Boeckh, C.; Gebicke, P.; Otten, U. 1989: Interleukin 1 stimulates the synthesis and release of nerve growth factor ngf in cultured arterial smooth muscle cells. Experientia 45(ABSTR): A68
Wood, R.G.; Goodman, R.B.; Kinasewitz, G.T.; Hanson Painton, O. 1991: Interleukin 1 stimulates transcriptional regulation of human mesothelial cell interleukin 8 production. Clinical Research 39(2): 289A
Bagby, G.C.; Shaw, G.; Heinrich, M.C.; Hefeneider, S.; Brown, M.A.; Deloughery, T.G.; Segal, G.M.; Band, L. 1990: Interleukin 1 stimulation stabilizes gm csf messenger rna in human vascular endothelial cells preliminary studies on the role of the 3 au rich motif. Dainiak, N , Et Al Progress in Clinical And Biological Research, Vol 352 The Biology Of Hematopoiesis; 15th Annual Frederick Stohlman, Jr , M D , Memorial Symposium: An International Symposium on The Biology Of Hematopoiesis, Cambridge, Massachusetts, Usa, October 15-20, 1989 Xxvii+554p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 233-240
Pau K Y.F.; Berria, M.J.; Spies, H.G. 1990: Interleukin 1 suppresses lh secretion without changing hypothalamic gnrh release. Society for Neuroscience Abstracts 16(2): 953
Lazenby, A.W.; Owen Schaub, L.B.; Crump, W.L.; Grimm, E.A.; Roth, J.A. 1991: Interleukin 1 synergizes with interleukin 2 in the generation of cytotoxic lymphocytes via a tumor necrosis factor mediated pathway. Surgical Forum 42: 472-475
Di Giovine, F.S.; Duff, G.W. 1990: Interleukin 1: the first interleukin. Immunology Today 11(1): 13-20
Shinmei, M.; Masuda, K.; Kikuchi, T.; Shimomura, Y. 1989: Interleukin 1, tumor necrosis factor, and interleukin 6 as mediators of cartilage destruction. Seminars in Arthritis and Rheumatism 18(3 Suppl 1: 27-32
Yard, B.A.; Boswell, R.N.; Schrama, E.; Van Es, L.A.; Daha, M.R.; Van Der Woude, F.J. 1993: Interleukin 1-alpha enhances the production of interleukin 6 by human proximal tubular epithelial cells in vitro. Kidney International 43(4): 970-971
Kumon, Y.; Schreiber, B.M.; Brinckerhoff, C.E.; Sipe, J.D. 1996: Interleukin 1-alpha induces APO serum amyloid A-3 synthesis and secretion by cultured neonatal rabbit aortic smooth muscle cells. Molecular Biology of the Cell 7(Suppl ): 147A
West Mays, J.A.; Sadow, P.M.; Strissel, K.J.; Cintron, C.; Fini, M.E. 1995: Interleukin 1-alpha mediates collagenase synthesis in passaged corneal fibroblasts and fibroblasts isolated from penetrating keratectomy wounds. IOVS Investigative Ophthalmology and Visual Science 36(4): S866
Malet, F.; Sale, Y.; Roncin, S.; Cochener, B.; Colin, J. 1995: Interleukin 1-alpha tear levels in eyes with keratoconus and keratoconus suspects. IOVS Investigative Ophthalmology and Visual Science 36(4): S999
Janiak, P.; Villeneuve, N.; Pillon, A.; Jacquermin, C.; Vilaine, J.P. 1996: Interleukin 1-beta aggravated the neointima formation after injury despite inducing nitric oxide synthase in rat carotid artery. FASEB Journal 10(3): A619
Torres, Paulo; De Vos, Alex; Van Der Gaag, Ruth; Kijlstra, Aize 1995: Interleukin 1-beta and interleukin 1 receptor antagonist expression during experimental corneal graft rejection. IOVS Investigative Ophthalmology and Visual Science 36(4): S1009
Gramantieri, L.; Casali, A.; Gaiani, S.; Piscaglia, F.; Grazi, G.; Stecca, B.; Masi, L.; Mazziotti, A.; Bolondi, L. 1996: Interleukin 1-beta and interleukin 1 receptor antagonist mRNA expression in hepatocellular carcinoma on liver cirrhosis. Italian Journal of Gastroenterology 28(5): 296-297
Neu, A.; Fivush, B.; Lederman, H. 1992: Interleukin 1-beta and tumor necrosis factor alpha production by peripheral blood mononuclear cells from chronic peritoneal dialysis patients. Journal of the American Society of Nephrology 3(3): 660
Justice, E.; Stylianou, E. 1997: Interleukin 1-beta and tumour necrosis factor alpha induce apoptosis in renal mesangial cells in vitro. Clinical Science 93(2): 13P-14P
Vinci, C.; Costantino, A.; Milazzo, G.; Gliozzo, B.; Vigneri, R.; Belfiore, A. 1993: Interleukin 1-beta antagonizes insulin and IGF1 mitogenic action on breast cancer cells. De Bellis, A, Marschke, K B Serono Symposia Publications from Raven Press; New perspectives in endocrinology: 317-320
Pringle, A.K.; Gardner, C.R.; Walker, R.J. 1993: Interleukin 1-beta attenuates GABA-A responses in the in vitro rat cerebellar slice through an indomethacin insensitive mechanism. Journal of Neurochemistry 61(Suppl ): S166
Oikawa, T.; Kakuchi, J.; Fogo, A. 1995: Interleukin 1-beta converting enzyme is increased in association with pathological apoptosis in the sclerotic kidney. Journal of the American Society of Nephrology 6(3): 1026
Oikawa, T.; Kakuchi, J.; Fogo, A. 1995: Interleukin 1-beta converting enzyme is increased in settings of increased apoptosis in vivo. Modern Pathology 8(1): 160A
Kannan, H.; Iki, K.; Kunitake, T.; Hirota, K.; Hanamori, T.; Tanaka, H.; Ueta, Y.; Hahashida, Y.; Yamashita, H. 1993: Interleukin 1-beta decreases urinary sodium and potassium excretion in conscious rats Possible involvement of renal sympathetic nerve activity. Society for Neuroscience Abstracts 19(1-3): 503
Damerau, K.; Boruchoff, S.E.; Paradiso, M.J.; Alcid, D.V. 1993: Interleukin 1-beta does not enhance the killing of Escherichia coli by normal human serum or by antibiotics. Abstracts of the General Meeting of the American Society for Microbiology 93: 94
Mitra, D.A.; Werner, P.A.; Giles, B.; Arias, A.I.; Pandey, J.P.; Silver, R.M. 1996: Interleukin 1-beta gene polymorphism in scleroderma. Arthritis and Rheumatism 39(9 Suppl): S233
Kawatani, M.; Fukuoka, H.; Hisamitsu, T. 1993: Interleukin 1-beta increased afferent activity from the urinary bladder. Japanese Journal of Physiology 43(Suppl 2): S263
Dunger, A.; Schlosser, M.; Ziegler, B.; Schmidt, S. 1995: Interleukin 1-beta induces apoptosis in insulin-producing cells. Diabetologia 38(Suppl 1): A38
Tanigawa, K.; Kato, Y. 1995: Interleukin 1-beta inhibits ATP-sensitive K+ channels induced by glucose but not those induced by tolbutamide. Medical Science Research 23(6): 429-430
Nadler, R.B.; Koch, A.E.; Campbell, P.L.; Rajan, N.; Schaeffer, A.J. 1998: Interleukin 1-beta levels in men with chronic prostatitis pelvic pain syndrome. Journal of Urology 159(5 Suppl): 271
Casamenti, F.; Prosperi, C.; Scali, C.; Giovannelli, L.; Bianchi, L.; Bartolini, P.; Pepeu, G. 1997: Interleukin 1-beta or beta amyloid peptide injections into the nucleus basalis increase extracellular GABA levels in the cortex of adult rats Role of nitric oxide?. Society for Neuroscience Abstracts 23(1-2): 1892
Young, J.E.; Friedman, C.I.; Danforth, D.R. 1994: Interleukin 1-beta stimulates prostaglandin-F2-alpha production by primate luteal cells in vitro during the mid and late-luteal phase. Biology of Reproduction 50(Suppl 1): 151
Guan, Y.; Zhao, Z.; Wang, H. 1993: Interleukin 1-beta stimulates the formation of nitric oxide and expression of endothelin-1 in human mesangial cells. Journal of the American Society of Nephrology 4(3): 552
Mcdonagh, A.J.G.; Elliott, K.R.; Messenger, A.G. 1996: Interleukin 1-beta stimulation of interleukin-6 production by cultured dermal papilla cells in alopecia areata. van Neste, D, Randall, V A International Congress Series; Hair research for the next millenium 249-251
Bertin, P.B.; Bonnet, C.; Kenney, J.S.; Welch, M.R.; Chiu, S.; Arnaud, M.; Treves, R. 1992: Interleukin 1-beta, 6 and 8 levels in osteoarthritis and rheumatoid arthritis synovial fluid. Arthritis and Rheumatism 35(9 Suppl): S306
Wong, M.L.; Bongiorno, P.B.; Rettori, V.; Mccann, S.M.; Licinio, J. 1997: Interleukin 1-beta, interleukin 1 receptor antagonist, interleukin 10, and interleukin 13 gene expression in the central nervous system and anterior pituitary during systemic inflammation Pathophysiological implications. Journal of Investigative Medicine 45(3): 238A
Plourde, V.; Boivin, M.; Mcduff, J. 1995: Interleukin 1-beta-induced inhibition of gastric emptying in the rat Role of the autonomic nervous system and nitric oxide. Gastroenterology 108(4 Suppl): A669
Dunger, A.; Schmidt, S. 1996: Interleukin 1-beta-induced inhibition of insulin secretion is counteracted by compounds which reduce nitric oxide production and stabilize islet energy production. European Journal of Endocrinology 134(Suppl 1): 12
Boehringer, N.; Songeon, F.; Dayer, J.M.; Nicod, L.P. 1995: Interleukin 10 and TNF-alpha are differently regulated by phorbol ester in alveolar macrophages. European Respiratory Journal 8(Suppl 19): 552S
Brouet, J.C.; Levy, Y. 1994: Interleukin 10 and germinal center B cells. M-S (Medecine Sciences) 10(6-7): 726-727
Winterholler, M.; Landgraf, S.; Roesel, T.; Erbguth, F.; Claus, D.; Neundoerfer, B. 1996: Interleukin 10 and its relationship to other cytokines in human bacterial meningitis. Neurology 46(2 Suppl): A316
Becherel, P.A.; Mossalayi, M.D.; Le Goff, L.; Dugas, B.; Debre, P.; Arock, M. 1995: Interleukin 10 and retinoic acid derivatives inhibit nitric oxide synthase induction and cytokine synthesis in human keratinocytes. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 789
Miossec, P.; Chomarat, P.; Rissoan, M.C.; Banchereau, J. 1993: Interleukin 10 and rheumatoid synovitis. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 146
Majeed, G.; Glew, S.; Bidwell, J.L. 1997: Interleukin 10 and tumour necrosis factor alpha promoter polymorphism and cervical lesions. Immunology 92(Suppl 1): 62
Schreiber, S.; Reinking, R.; Panzer, U.; Heinig, T.; Raedler, A. 1995: Interleukin 10 downregulates IBD mononuclear phagocyte activation in vitro and in vivo. Gastroenterology 108(4 Suppl): A914
Stegen, C.; Bouterfa, H.; Huettner, C.; Czub, S.; Kerkau, S.; Roggendorf, W.; Roosen, K.; Tonn, J.C. 1997: Interleukin 10 enhances the expression of the matrix metalloprotease matrilysin and the invasiveness in the human glioma cell line U373. Proceedings of the American Association for Cancer Research 38: 405
Okayama H.; Akai S.; Okayama M.; Nakazawa H.; Satoh M.; Shimura S.; Maruyama N.; Yamauchi K.; Tamura G.; Et Al 1992: Interleukin 10 gene expression in asthma. American Review of Respiratory Disease 145(4 Part 2): A239
Bernstein, M.S.; Reiner, S.L.; Golden, J.A.; Locksley, R.M. 1992: Interleukin 10 gene expression induction by fc receptor crosslinking in monocyte macrophages and expression by alveolar cells. Clinical Research 40(2): 186A
Crusius, J.B.A.; Centeno, C.M.P.rez; Keijsers, V.; Bouma, G.; Meuwissen, S.G.M.; Huizinga, T.W.J.; Pena, A.S. 1998: Interleukin 10 gene polymorphisms in ulcerative colitis and Crohns disease. Gastroenterology 114(4 Part 2): A957
Sherwood, J.B.; Dunton, C.J.; Sato, T. 1998: Interleukin 10 in epithelial ovarian cancer. Gynecologic Oncology 68(1): 89
Li, L.; Xia, X.; Choi, Y.S. 1994: Interleukin 10 in human B cell differentiation. FASEB Journal 8(4-5): A256
Li, L.; Xia, X.; Zhang, X.H.; Choi, Y.S. 1996: Interleukin 10 induce SAC activated B cells undergo apoptosis through down-regulation of BCL-X-L expression. FASEB Journal 10(6): A1066
Koppelman, B.; Neefjes, J.J.; De Vries, J.E.; De Waal Malefyt, Rene 1997: Interleukin 10 inhibits arrival of mature MHC class II alpha-beta peptide complexes to the plasma membrane in human monocytes. Journal of Allergy and Clinical Immunology 99(1 Part 2): S450
Taga, K.; Tosato, G. 1992: Interleukin 10 inhibits human t cell proliferation and il 2 production. FASEB Journal 6(4): A1333
Schwarz, A.; Grabbe, S.; Simon, M.; Aragane, Y.; Luger, T.A.; Zlotnik, A.; Schwarz, T. 1993: Interleukin 10 inhibits the effector phase of contact hypersensitivity. Journal of Investigative Dermatology 100(4): 521
Zlotnik, A.; Chen, W.F. 1991: Interleukin 10 is a cytotoxic t cell differentiation factor. FASEB Journal 5(5): A974
Steinhauser, M.L.; Hogaboam, C.M.; Kunkel, S.L.; Lukacs, N.W.; Strieter, R.M.; Standiford, T.J. 1998: Interleukin 10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense. FASEB Journal 12(5): A807
Fleming, S.D.; Campbell, P.A. 1995: Interleukin 10 is biologically active on macrophage cell surfaces. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 348
Finke, J.; Ternes, P.; Lange, W.; Mertelsmann, R.; Doelken, G. 1992: Interleukin 10 is heterogeneously expressed in acute and chronic lymphocytic leukemia. Annals of Hematology 65(Suppl ): A54
Osawa, H.; Yamabe, Y.; Inuma, H.; Kaizuka, M.; Tamura, N.; Tsunoda, S.; Fujita, Y.; Shirato, K.; Takanashi, S.; Onodera, K. 1995: Interleukin 10 modulates mesangial cell proliferation and its IL-6 production. Journal of the American Society of Nephrology 6(3): 846
Thomassen, M.J.; Buhrow, L.T.; Fisher, C.J. 1996: Interleukin 10 modulates superantigen induced cytokine production by human alveolar macrophages. Molecular Biology of the Cell 7(Suppl ): 145A
Sato, T.; Masuoka, K.; Lattime, E.C.; Mastrangelo, M.J.; Dunton, C.J.; Sherwood, J.B.; Berd, D. 1997: Interleukin 10 production by adenocarcinomas. Proceedings of the American Association for Cancer Research 38: 34
Spalwski, J.B.; Yamamolto, K.; Fink, C.; Lipsky, P.E. 1997: Interleukin 10 production is not increased in juvenile chronic arthritis. Journal of Allergy and Clinical Immunology 99(1 Part 2): S194
Splawski, J.B.; Lipsky, P.E. 1994: Interleukin 10 promotes IL-2 dependent immunoglobulin secretion by neonatal B cells. Pediatric Research 35(4 Part 2): 256A
Londoño, D.; Carvajal, J.; Arguelles-Grande, C.; Marques, A.; Cadavid, D. 2008: Interleukin 10 protects the brain microcirculation from spirochetal injury. Journal of Neuropathology and Experimental Neurology 67(10): 976-983
Lasker, M.R.; Palmer, R.; Wedgwood, J. 1997: Interleukin 10 receptor in the newborn. Pediatric Research 41(4 Part 2): 217A
Vaquerano, J.E.; Zhou, Y.M.; Peng, M.; Biggs, M.W.; Chang, J.W.C.; Leong, S.P.L. 1998: Interleukin 10 reduction in peripheral blood mononuclear cells following active specific immunization with autologous melanoma vaccine and granulocyte macrophage-colony stimulating factor. Proceedings of the American Association for Cancer Research 39: 10
Kuhlmann, F.; Roehlig, C.; Lukoschek, M.; Heilig, B. 1993: Interleukin 10 regulates TNF and TNF receptor expression in synovial mononuclear cells. Arthritis and Rheumatism 36(9 Suppl): S158
Van Vlasselaer, P. 1994: Interleukin 10 supports the growth of granulocyte/macrophage colony forming cells in mouse bone marrow cultures by blocking endogenous TGF-beta-1 synthesis. Journal of Cellular Biochemistry Suppl 1994(18 Part A): 22
Gu, Y.; Yang, J.; Ouyang, X.; Liu, W.; Li, H.; Yang, J.; Bromberg, J.; Chen, S.-H.; Mayer, L.; Unkeless, J.C.; Xiong, H. 2008: Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells. European Journal of Immunology 38(7): 1807-1813
Huang, S.; Xie, K.; Bucana, C.D.; Ullrich, S.; Bar Eli, M. 1996: Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells by inhibiting angiogenesis. Proceedings of the American Association for Cancer Research 37: 508
Tumpey, T.; Elner, V.; Oakes, J.E.; Lausch, R.N. 1994: Interleukin 10 treatment can suppress stromal keratitis induced by HSV-1. IOVS Investigative Ophthalmology and Visual Science 35(4): 1332
Goldman, M.; Velu, T. 1993: Interleukin 10, a new immunosuppressive and antiinflammatory cytokine. M-S (Medecine Sciences) 9(4): 453-455
Fulton, A.M.; Kundu, N.; Beaty, T.; Jackson, M.J. 1995: Interleukin 10-mediated inhibition of mammary tumor growth and metastasis. FASEB Journal 9(3): A206
Oyajobi, B.O.; Houghton, A.; Liu, P.; Hasan, H.; Stringer, B.M.J.; Russell, R.G.G. 1995: Interleukin 11 and transforming growth factor-beta but not interleukin 4 inhibit interleukin 6 production by immortalized human bone marrow stromal cells. Bone (New York) 17(6): 570
Donaldson, D.; Neben, S.; Turner, K. 1992: Interleukin 11 in combination with other hematopoietic growth factors supports the survival and expansion of primitive murine progenitor cells in vitro. Journal of Cellular Biochemistry Suppl (16 Part C): 73
Greenwood Van Meerveld, B.; Tyler, K.; Keith, J. 1997: Interleukin 11 modulates ion transport in the small intestine and colon of normal and HLA-B27 rats. Gastroenterology 112(4 Suppl): A985
Neben, S.; Donaldson, D.; Yetz Aldape, J.; Turner, K.; Clark, S. 1992: Interleukin 11 synergizes with il 3 and steel factor but not with il 6 on proliferation of primitive murine hematopoietic stem cells in vitro. Experimental Hematology (Charlottesville) 20(6): 735
Lamont, A.G.; Gibson, V.; Carr, J.; Rogerson, J.; Pole, D.S.; Mulqueen, M.J.; Roberts, N.A.; Booth, R.F.G. 1995: Interleukin 12 A potent anti-viral agent against murine cytomegalovirus infection. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY The 9th International Congress of Immunology : 357
Clark, S.C. 1994: Interleukin 12 Molecular, biological and clinical perspectives. Abraham, N G , Shadduck, R K , Levine, A S , Takaku, F Molecular biology of haematopoiesis, Vol 3 3-14
Aulitzky, W.E.; Goey, H.; Stoter, G.; Peschel, C.; Schuler, M.; Huber, C. 1996: Interleukin 12 Preliminary clinical results of a phase I trial with three times weekly sc administration of human recombinant IL-12 in patients with advanced renal cell cancer. Annals of Hematology 73(Suppl 2): A75
Mikus, L.D.; Sorkness, R.L.; Lemanske, R.F. 1998: Interleukin 12 and 18 modulation of interferon-gamma production in atopic and nonatopic rats. Journal of Allergy and Clinical Immunology 101(1 Part 2): S42
Anderson, R.; Macdonald, I.; Corbett, T.; Lowdell, M.; Prentice, H.G.ant 1996: Interleukin 12 and CD80 co-expression from an adeno-associated virus vector. British Journal of Haematology 93(Suppl 2): 158
Hoag, K.; Lipscomb, M.; Street, N. 1996: Interleukin 12 and interferon-gamma are required for resistance to a pulmonary Cryptococcus neoformans infection in mice. FASEB Journal 10(6): A1437
Sturmhoefel, K.; Lee, K.; Toole, M.O.; Swiniarski, H.M.; Dorner, A.J.; Wolf, S.F. 1998: Interleukin 12 as vaccine adjuvant. Research in Immunology 149(1): 37-39
Wolf, S.F.; Bliss, J.; Vancleave, V.; Murray, K.; Wiencis, A.; Ketchum, M.; Maylor, R.; Haire, T.; Resmini, C.; Abbas, A. 1995: Interleukin 12 as vaccine adjuvant with soluble antigen, promotes a T helper cell type 1 recall response. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 164
Wolf, S.F.; Bliss, J.; Vancleave, V.; Murray, K.; Wiencis, A.; Ketchum, M.; Maylor, R.; Haire, T.; Resmini, C.; Abbas, A. 1995: Interleukin 12 as vaccine adjuvant, promotes T helper cell type 1 and suppresses Th cell type 2 immune responses. Cancer Biotherapy 10(1): 81
Kincy Cain, T.; Clements, J.D.; Bost, K.L. 1996: Interleukin 12 augments mucosal immunity against oral Salmonella IL-12 production by murine intestinal epithelial cells. FASEB Journal 10(6): A1436
Schwarz, A.; Grabbe, S.; Aragane, Y.; Sandkuhl, K.; Riemann, H.; Luger, T.; Kubin, M.; Trinchieri, G.; Schwarz, T. 1996: Interleukin 12 breaks UV-induced tolerance. Journal of Investigative Dermatology 106(4): 931
Degiannis, D.; Koniavitou, K. 1996: Interleukin 12 dependent proliferation OKT3-preactivated peripheral blood mononuclear cells Effect of cyclosporine and rapamycin. Journal of Heart and Lung Transplantation 15(1 Part 2): S64
Bhardwaj, N.; Seder, R.A.; Reddy, A.; Feldman, M.V. 1996: Interleukin 12 enhances human CD8+ cytolytic T cell responses. Arthritis and Rheumatism 39(9 Suppl): S265
Bhardwal, N.; Reddy, A.; Feldman, M.V. 1996: Interleukin 12 enhances human anti-viral CD8+ cytolytic T cell responses induced by dendritic cells. Journal of Investigative Medicine 44(3): 222A
Dearman, R.J.; Kimber, I. 1997: Interleukin 12 expression during murine immune response to chemical allergens. Human and Experimental Toxicology 16(7): 376
Hara, I.; Gohji, K.; Arakawa, S.; Kamidono, S. 1997: Interleukin 12 gene transfer to mouse renal cell carcinoma cell line results in tumor rejection in syngeneic hosts. Journal of Urology 157(4 Suppl): 107
Houssiau, F.A.; Mascart Lemone, F.; Devogelaer, J.P.; Goldman, M.; Renauld, J.C. 1996: Interleukin 12 inhibits in vitro immunoglobulin production by SLE peripheral blood mononuclear cells. Arthritis and Rheumatism 39(9 Suppl): S250
Moiola, L.; Galbiati, F.; Martino, G.; Amadio, S.; Brambilla, E.; Comi, G.; Vincent, A.; Grimaldi, L.M.E.; Adorini, L. 1998: Interleukin 12 is critical in the development of experimental autoimmune myasthenia gravis. Journal of Neuroimmunology 90(1): 92
Rook, A.H.; Yoo, E.K.; Wood, G.S.; Elenitsas, R.; Fox, F.E.; Niu, Z.; Sherman, M.L.; Kao, D.; Lessin, S.R.; Vonderheid, E.C. 1998: Interleukin 12 is safe and effective therapy for cutaneous T-cell lymphoma. Journal of Dermatological Science 16(Suppl 1): S208
Rook, A.H.; Kang, K.; Kubin, M.; Cassin, M.; Trinchieri, G.; Lessin, S.R.; Cooper, K.D. 1994: Interleukin 12 mRNA and protein production by epidermal Langerhans cells. Clinical Research 42(2): 231A
Rossol, S.; Carucci, P.; Marinos, G.; Singer, M.; Williams, R.; Naoumov, N.V. 1997: Interleukin 12 production and TH1/TH2 responses in vitro in patients with chronic hepatitis B virus infection. Journal of Hepatology 26(Suppl 1): 112
Dearman, R.J.; Kimber, I. 1997: Interleukin 12 production by murine allergen-activated lymph node cells. Journal of Allergy and Clinical Immunology 99(1 Part 2): S53
Schwarz, A.; Grabbe, S.; Aragane, Y.; Sandkuhl, K.; Riemann, H.; Luger, T.A.; Kubin, M.; Trinchieri, G.; Schwarz, T. 1995: Interleukin 12 reverses UVB-induced suppression of the induction of contact sensitivity. Journal of Investigative Dermatology 104(4): 588
Bussolati, B.; Mariano, F.; David, S.; Caserta, C.; Camussi, G.; Cambi, V. 1997: Interleukin 12 stimulates the synthesis of platelet activating factor from human cultured mesangial cells. Nephrology Dialysis Transplantation 12(9): A18
Dybedal, I.; Jacobsen, S.E.W. 1994: Interleukin 12 synergistically and directly enhances in vitro erythropoiesis. British Journal of Haematology 87(Suppl 1): 95
Magurie, H.C.Jr 1995: Interleukin 12 upregulates the T cell immune response. Journal of Cellular Biochemistry Suppl 1995(21A): 77
Kimber, I.; Dearman, R.J. 1997: Interleukin 12-dependent expression of interferon gamma by CD4+ and CD8+ allergen-activated lymph node cells. Immunology 92(Suppl 1): 31
Hegazy, D.; Thurairajah, P.; Metzner, M.; Houldsworth, A.; Shaw, S.; Kaminski, E.; Demaine, A.G.; Cramp, M.E. 2008: Interleukin 12B gene polymorphism and apparent resistance to hepatitis C virus infection. Clinical and Experimental Immunology 152(3): 538-541
Hoshino, T.; Winkler Pickett, R.T.; Mason, A.T.; Ortaldo, J.R.; Young, H.A. 1998: Interleukin 13 production by NK cells Induction by IL-2 and IL-15. Natural Immunity 16(2-3): 62
Murata, T.; Taguchi, J.; Puri, R.K. 1997: Interleukin 13 receptor alpha chain is a functional component of interleukin 4 receptor and JAK2 is required for its signal transduction. Blood 90(10 Suppl 1 Pt 1): 168A
Zurawski, G.; de Vries, J.E. 1994: Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunology Today 15(1): 19-26
McInnes, I.B.; Liew, F.Y. 1998: Interleukin 15: a proinflammatory role in rheumatoid arthritis synovitis. Immunology Today 19(2): 75-79
Treiber Held, S.A.; Stewart, D.M.; Kurman, C.C.; Barraclough, H.A.; Nelson, D.L. 1996: Interleukin 15 activates human peripheral blood mononuclear cells in the absence of other exogenous stimuli. Journal of Investigative Medicine 44(3): 231A
Kusugami, K.; Sakai, T.; Ina, K.; Ando, T.; Noshiro, M.; Shimada, M.; Yoshikai, Y. 1998: Interleukin 15 activity and its modulatory effects on local immune cells in patients with inflammatory bowel disease. Gastroenterology 114(4 Part 2): A1016
Basak, G.W.; Zapala, L.; Wysocki, P.J.; Mackiewicz, A.; Jakóbisiak, M.; Lasek, W. 2008: Interleukin 15 augments antitumor activity of cytokine gene-modified melanoma cell vaccines in a murine model. Oncology Reports 19(5): 1173-1179
Vazquez, N.; Lyman, C.A.; Friedman, D.; Walsh, T.J.; Chanock, S.J. 1995: Interleukin 15 augments human monocyte activation. Blood 86(10 Suppl 1): 32A
Wood, C.J.; Spurrell, J.C.L.; Mody, C.H. 1997: Interleukin 15 can restore human lymphocyte proliferation to Cryptococcus neoformans when interleukin 2 is blocked. Abstracts of the General Meeting of the American Society for Microbiology 97: 240
Jellie, S.E.; Revell, P.A. 1997: Interleukin 15 in the implant interface membrane from total joint replacements. Journal of Pathology 181(Suppl): 46A
Mrozek, E.; Wetzler, M.; Anderson, P.; Caligiuri, M.A. 1996: Interleukin 15 induces CD56+ large granular lymphocytes from CD34+ progenitor cells. Proceedings of the American Association for Cancer Research 37: 454
Gamero, A.M.; Ussery, D.; Reintgen, D.S.; Puleo, C.A.; Djeu, J.Y. 1995: Interleukin 15 induction of lymphokine activated killer cell function against autologous tumor cells in melanoma patient lymphocytes autologous tumor cells in melanoma patient lymphocytes by a CD18 dependent, perforin-related mechanism. Blood 86(10 Suppl 1): 322
Holton, R.H.; Bost, K.L. 1996: Interleukin 15 is upregulated in mucosal tissues following oral inoculation with Salmonella A possible role for IL-15 in the immune response against this pathogen. FASEB Journal 10(6): A1167
Stevens, A.C.; Maslinski, W.; Bitton, A.; Peppercorn, M.A.; Strom, T.B. 1995: Interleukin 15 mRNA transcripts in ulcerative colitis colonic specimens. Gastroenterology 108(4 Suppl): A923
Center, D.M.; Kornfeld, H.; Cruikshank, W.W. 1996: Interleukin 16 and its function as a CD4 ligand. Immunology Today 17(10): 476-481
Alzoebie, A.; Schwarzenberger, P.; Miller, A.; Kolls, J.K.; Scher, C.D.; Warrier, R.P.; La Russa, V.F. 1998: Interleukin 17 regulates the recruitment of early stromal progenitors into colony formation. Experimental Hematology 26(8): 734
Li, J.-M.; Eslami, M.H.; Rohrer, M.J.; Dargon, P.; Joris, I.; Hendricks, G.; Baker, S.; Cutler, B.S. 2008: Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia after balloon injury in an atherosclerotic rabbit model. Journal of Vascular Surgery 47(5): 1048-1057
Micallef, M.J.; Hanaya, T.; Kohno, K.; Arai, S.; Tanimoto, T.; Ikeda, M.; Kurimoto, M. 1997: Interleukin 18 exhibits antitumor effects in mice challenged intraperitoneally with syngeneic Meth A sarcoma. Proceedings of the American Association for Cancer Research 38: 357
Kohno, K.; Kurimoto, M. 1998: Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clinical Immunology and Immunopathology 86(1): 11-15
Dresback, J.; Katz, J.; Nelson, H.S.; Rosenwasser, L.J. 1994: Interleukin 1B detection in nasal lavage and tissue of allergic subjects. Journal of Allergy and Clinical Immunology 93(1 Part 2): 288
Cumberbatch, M.; Dearman, R.J.; Kimber, I. 1998: Interleukin 1alpha exhibits the potential to contribute to epidermal Langerhans cell migration. British Journal of Dermatology 138(4): 736
Zaldivar, F.Jr; Berman, M.A.; Imfeld, K.L.; Sandborg, C.I. 1998: Interleukin 1alpha promoter activity in human T cells. FASEB Journal 12(4): A263
Cumberbatch, M.; Dearman, R.J.; Kimber, I. 1998: Interleukin 1alpha provokes Langerhans cell migration in an interleukin 1beta-dependent manner. Immunology 95(Suppl 1): 127
Cumberbatch, M.; Dearman, R.J.; Kimber, I. 1998: Interleukin 1alpha required for Langerhans cell migration provoked in mice by the skin irritant sodium lauryl sulphate. Human and Experimental Toxicology 17(9): 497
Daymond, T.J.; Rowell, F.J. 1990: Interleukin 1b and its relationship to collagenase prostaglandin e 2 and drug treatment in rheumatoid arthritis. British Journal of Rheumatology 29(Suppl 1): 16
Hurst, S.M.; Collins, S.M. 1991: Interleukin 1b h ril i b inhibits the release of tritiated noradrenaline na from rat myenteric plexus. FASEB Journal 5(5): A1273
Panagakos, F.S.; Jandinski, J.J.; Fenesy, K.E.; Deasy, M.J. 1990: Interleukin 1b in crevicular fluid from patients with juvenile periodontitis. Journal of Dental Research 69(Special Issue): 327
Lynch, P.R.; Davidovitch, Z.; Shanfeld, J. 1989: Interleukin 1b levels in cells during tooth eruption and resorption. Journal of Dental Research 68(Special Issue): 287
Lyons Giordano, B.; Davis, G.L.; Galbraith, W.; Pratta, M.A.; Arner, E.C. 1990: Interleukin 1b stimulates phospholipase a 2 messenger rna synthesis in rabbit articular chondrocytes. FASEB Journal 4(7): A1714
Yang, W.S.; Kim, S.B.; Park, S.; Lee, S.K.; Park, J.S. 1997: Interleukin 1beta induces morphologic change and increased production of MCP-1 and extracellular matrix in human peritoneal mesothelial cells. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 276A
Culig, Z.; Hobisch, A.; Herold, M.; Hittmair, A.; Thurnher, M.; Eder, I.E.; Cronauer, M.V.; Rieser, C.; Ramoner, R.; Bartsch, G.; Klocker, H.; Konwalinka, G. 1998: Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells. British Journal of Cancer 78(8): 1004-1011
Gallo, V.; Sidoli, L.; Riva, P.; Cantoni, R.; Bisbocci, D. 1998: Interleukin 1beta system in chronic ethanol addiction. Journal of Hepatology 28(Suppl 1): 219
Dixon, B.S.; Evanoff, D.; Dennis, M.J. 1998: Interleukin 1beta upregulates the bradykinin B1 receptor and enhances B1R-mediated inhibition of platelet-derived growth factor -stimulated mitogenesis in arterial smooth muscle cells. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 438A
Hamad, A.; Bakr, A.; Hagar, M.; Mansor, A.; Shenawy, F.; Domyati, H.; Sarhan, A. 1998: Interleukin 2 , interleukin 4 , and interferon gamma in primary nephrotic syndrome. Pediatric Nephrology 12(7): C96
Shinohara, T.; Sugimoto, Y.; Sato, S.; Tsukahara, S.; Sone, S.; Tsuruo, T. 1996: Interleukin 2 -gene transfer into multidrug-resistant human ovarian cancer cells enhances therapeutic efficacy of anti-P-glycoprotein antibody. Proceedings of the American Association for Cancer Research 37: 309
Fradelizi, D.; Quillet, A. 1989: Interleukin 2 a lymphocyte growth hormone with large immunotherapeutic potentials. Bolla, M , E M Chambaz And C Vrousos (Ed ) Colloque Inserm (Institut National De La Sante Et De La Recherche Medicale), Vol 190 Facteurs De Croissance Et Oncogenes; (Inserm (National Institute Of Health And Medical Research) Colloquium, Vol 190 Growth Factors And Oncogenes); 8th Cancer Symposium Of Grenoble, Grenoble, France, March 10-11, Xi+222p Les Editions Inserm: Paris, France Illus Paper 55-60
Smith, K.A. 1989: Interleukin 2 a prototype of the new lymphocytotropic hormones that regulate the immune system. Degroot, L J , Et Al (Ed ) Endocrinology, Second Edition, Vols 1-3 Xxxii+801p (Vol 1); Xxxii+996p (Vol 2); Xxxii+979p (Vol 3) W B Saunders, Co : Philadelphia, Pennsylvania, Usa Illus 2454-2465
Verstovsek, S.; Casey, C.; Mihich, E.; Ehrke, M.J. 1995: Interleukin 2 activated splenic NK 11 negative adherent macrophages lyse natural killer sensitive YAC-1 tumor cells in 4 hours. FASEB Journal 9(4): A1040
Casnellie, J.E.; Saltzman, E.M. 1989: Interleukin 2 activates a tyrosine protein kinase through the 75kd receptor on human leukemia cell lines. Journal of Cellular Biochemistry Suppl (13 Part B): 119
Brach, M.; Gruss H J.; Riedel, D.; Mertelsmann, R.H.; Herrmann, F. 1991: Interleukin 2 activates nfkb binding activity and auto regulates transcriptional activity of its own receptor gene by normal human monocytes engaging nfkb. Onkologie 14(Suppl 2): 20
Mathews, H.L. 1991: Interleukin 2 activation of lymphocytes which mediate anti fungal activity. Cytokine 3(5): 491
Gyorffy, S.F.; Mcphedran, A.M.; Lee, S.E.; Kwok, C.S. 1995: Interleukin 2 activation of neutrophil adherence to HUVEC as a possible model for vascular leak syndrome. Proceedings of the American Association for Cancer Research 36: 498
Isaacs, W.B.; Partin, A.W.; Marshall, F.F. 1989: Interleukin 2 activation of t lymphocytes in primary cultures of human renal cell cancer monitoring by time lapse videomicroscopy. Proceedings of the American Association for Cancer Research 30: 370
Kozlow, E.J.; Carlson, P.; Glauser, F. 1989: Interleukin 2 alters sheep lung lymph lymphocyte cell surface antigenic expression. Clinical Research 37(2): 478A
Heaton, K.M.; Ju, G.; Grimm, E.A. 1993: Interleukin 2 analogs specific for the intermediate affinity IL-2 receptor generate lymphokine-activated killing with decreased IL-1-beta, TNF-alpha, and IFN-GAMMA production. Journal of Cellular Biochemistry Suppl 1993(17 Part B): 91
Chen J W. 1989: Interleukin 2 and adoptive immunotherapy. Zhongguo Zhongliu Linchuang 16(4): 230-232
Dummer, R.; Welters, H.; Keilholz, U.; Tilgen, W.; Burg, G. 1990: Interleukin 2 and adoptive immunotherapy in cancer treatment. Hautarzt 41(2): 53-55
Nakajima, F.; Khanna, A.; Xu, G.; Stenzel, K.H. 1993: Interleukin 2 and anti-CD3 monoclonal antibody are synergistic in inducing tumor regression. Journal of Urology 149(4 Suppl): 460A
Bubeník, J.; Símová, J.; Bubeníková, D. 1992: Interleukin 2 and cancer. Folia Biologica 38(3-4): 155-169
Nieweg, M.B.; Wagstaff, J. 1990: Interleukin 2 and colony stimulating factors nursing implications. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 2): 1050
Stevens, B.R.; Bosworth, J.; Feldman, D.; Kuhki, N.; Tellier, M.; Harvey, W. 1997: Interleukin 2 and concanavalin A regulate alternatively spliced feline CAT-2 gene encoding L-arginine transport. FASEB Journal 11(3): A328
Ogarkov, V.I.; Dobkin, A.I.; Ryzhova, E.V.; Okulov, V.B.; Kiselev, O.I. 1989: Interleukin 2 and immunotherapy for cancer. Voprosy Onkologii (St Petersburg) 35(2): 141-150
Hauschild, A.; Moenig, H.; Christophers, E.; Schulte, H.M. 1992: Interleukin 2 and interferon alpha suppress tsh secretion. Proceedings of the American Association for Cancer Research 33: 245
Finke, J.; Stanley, J.; Rayman, P.; Alexander, J.; Edinger, M.; Tubbs, R.; Sergi, J.; Bukowski, R. 1991: Interleukin 2 and interleukin 4 effects on growth and cytokine production of cd4 plus and cd8 plus til lines from renal cell carcinoma. Proceedings of the American Association for Cancer Research 32: 273
Costello, R. 1991: Interleukin 2 and its pleiotropic effects. British Journal of Haematology 79(2): 345
Cox, G.W.; Giardina, S.L.; Mathieson, B.J.; Varesio, B.J. 1989: Interleukin 2 and its receptor are both expressed in an immortalized murine macrophage cell line. FASEB Journal 3(3): A822
Thèze, J.; Alzari, P.M.; Bertoglio, J. 1996: Interleukin 2 and its receptors: recent advances and new immunological functions. Immunology Today 17(10): 481-486
Park C.S.; Uh S.T.; Chung Y.T.; Kim H.T.; Kim Y.H.; Lee H.B. 1992: Interleukin 2 and its soluble receptor in bronchoalveolar lavage fluid of the patients with bronchial asthma. American Review of Respiratory Disease 145(4 Part 2): A21
Yang, J.P.; Renzi, P.M. 1991: Interleukin 2 and lymphocyte induced eosinophil proliferation survival and activation in asthmatics. American Review of Respiratory Disease 143(4 Part 2): A801
Qian Y C.; Fairman, P.; Glauser, F. 1989: Interleukin 2 and not its excipient is responsible for pulmonary toxicity. Clinical Research 37(1): 26A
Perrin, P.; Cassagnau, E.; Burg, C.; Harb, J.; Le Pendu, J.; Meflah, J.Y. 1994: Interleukin 2 and sodium butyrate An efficient combination for immunotherapy of rat colon cancer peritoneal carcinomatosis. Proceedings of the American Association for Cancer Research 35: 524
Brenner, M.K. 1991: Interleukin 2 and the treatment of leukemia and lymphoma. Leukemia and Lymphoma 5(2-3): 77-83
Barnett, D.; Storr, J.; Buckley, G.A.; Reilly, J.T. 1989: Interleukin 2 and transferrin receptor expression in b cll an in vitro and in vivo study. Medical Laboratory Sciences 46(Suppl 1): S34
Durrant, L.G.; Denton, G.W.L.; Robins, R.A. 1992: Interleukin 2 and tumor necrosis factor alpha after human monoclonal anti idiotypic antibody immunization of colorectal cancer patients. Proceedings of the American Association for Cancer Research 33: 244
Kloc, M.; Stepkowski, S.M.; Kahan, B.D. 1991: Interleukin 2 antisense oligonucleotides inhibit in vitro functions of t cells. FASEB Journal 5(5): A973
Jiang, H.; Leu, R. 1991: Interleukin 2 as a natural triggering agent for interferon gamma primed murine macrophages to mediate tumor cytotoxicity role of tumor necrosis factor and nitric oxide. Journal of Leukocyte Biology (Suppl 2): 55
Weisdorf, D.J.; Anderson, P.M.; Kersey, J.H.; Ramsay, N.K.C. 1992: Interleukin 2 as adjunct immunotherapy following autologous marrow transplantation for acute lymphoblastic leukemia. Journal of Cellular Biochemistry Suppl (16 Part A): 199
Bergmann, L.; Fenchel, K.; Martin, H.; Jahn, B.; Mitrou, P.S.; Hoelzer, D. 1991: Interleukin 2 as late consolidation therapy in 2nd remission of acute myelocytic leukemia with and without autologous bone marrow transplantation. Onkologie 14(Suppl 2): 13
Melillo, G.; Cox, G.W.; Wang, J.M.; Varesio, L. 1992: Interleukin 2 augments je mrna expression and chemotactic activity in mouse macrophages. FASEB Journal 6(5): A1719
Ricci, W.M.; Darrow, T.; Vervaert, C.; Wahab, Z.; Seigler, H.F. 1991: Interleukin 2 augments the host response to tumor cells in a murine model of specific active immunotherapy. Surgical Forum 42: 475-477
Lotze, M.T. 1990: Interleukin 2 based immunotherapy of melanoma. Rumke, P (Ed ) Pigment Cell, Vol 10 Therapy Of Advanced Melanoma Viii+230p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 163-182
Merida, I.; Diez, E.; Gaulton, G. 1992: Interleukin 2 binding activates a tyrosine phosphorylated phosphatidylinositol 3 kinase. Journal of Cellular Biochemistry Suppl (16 Part B): 198
Sivinski, C.L.; Haya, Y.; Tempero, M.A. 1991: Interleukin 2 boosted antibody dependent cellular cytotoxicity using monoclonal antibody 17 a and pancreatic cancer cell lines. Proceedings of the American Association for Cancer Research 32: 229
Schacter, B.; Hansal, S. 1989: Interleukin 2 confers stress resistance upon human nk activity. Journal of Cellular Biochemistry Suppl (13 Part C): 76
Sukhabote, R.; Kwan, W.C.; Johnston, G.; Freeman, H. 1991: Interleukin 2 decreases d glucose transport in a cultured intestinal epithelial cell line iec 6. Gastroenterology 100(5 Part 2): A705
Cunningham Rundles, Charlotte 1993: Interleukin 2 deficiency in primary immunodeficiency Exploration of recombinant interleukin 2 as a potential in vivo treatment. Gupta, S , Griscelli, C New concepts in immunodeficiency diseases 391-416
Toribio, M.L.; Gutierrez Ramos, J.C.; Pezzi, L.; Marcos, M.A.R.; Martinez, A.C. 1989: Interleukin 2 dependent autocrine proliferation in t cell development. Nature (London) 342(6245): 82-85
Klappacher, G.; Papousek, A.; Micksche, M.; Glogar, D. 1990: Interleukin 2 dependent t cell activation in dilated cardiomyopathy as autoimmune mechanism. European Heart Journal 11(ABSTR Suppl): 280
Wall, K.A.; Kopperud, E.M.; Elbein, A.D.; Infante, A.J. 1990: Interleukin 2 dependent t cell proliferation is specifically affected by carbohydrate structural alteration. FASEB Journal 4(7): A1918
Djordjevic, N.; Draskovic Pavlovic, B.; Pejnovic, N.; Lilic, D.; Kataranovski, M.; Kukic, Z.; Dujic, A. 1990: Interleukin 2 detection in a cocultivation ctld bioassay. Periodicum Biologorum 92(Suppl 3): 49
Andreu, J.L.; Gutierrez, J.C.; Marcos, M.A.R.; Vegazo, I.; Martinez, A.C. 1990: Interleukin 2 directed expression by mean of recombinant vaccinia viruses confers protection against autoimmune disease in mrl lpr mice. British Journal of Rheumatology 29(ABSTR Suppl 2): 95
Ciacci, C.; Koizumi, M.; Podolsky, D.K. 1991: Interleukin 2 directly modulates intestinal epithelial cells. Gastroenterology 100(5 Part 2): A567
Forero, A.; Simpson, T.A.; Lobuglio, A.F.; Shaw, D.R. 1989: Interleukin 2 enhances antibody dependent cellular cytotoxicity by human monocytes and lymphocytes. Clinical Research 37(1): 33A
Gurbindo, C.; Agulnik, J.; Atlan, P.; Duhaime, A.; Seidman, E. 1990: Interleukin 2 enhances thymidine incorporation by a murine crypt intestinal cell line. Gastroenterology 98(5 Part 2): A413
Fujioka, T.; Hasegawa, M.; Ishikura, K.; Nomura, K.; Tanji, S.; Kubo, T.; Ohhori, T. 1992: Interleukin 2 expanded tumor infiltrating lymphocytes and their response to preoperative interferon alpha in patients with renal cell carcinoma. Journal of Urology 147(4 Suppl): 351A
Favrot, M.C.; Negrier, S.; Michon, U.; Blaise, D.; Oskan, R.; Bernard, J.L.; Palmer, P.; Philip, T. 1992: Interleukin 2 following autologous bone marrow transplantation for the treatment of malignant solid tumors. Onkologie 15(Suppl 1): 9
Mouzaki, A.; Rungger, D. 1994: Interleukin 2 gene regulation at the Pud promoter element The complex situation in primary T lymphocytes. Abraham, N G , Shadduck, R K , Levine, A S , Takaku, F Molecular biology of haematopoiesis, Vol 3 475-486
Tran A C.; Kang S M.; Beverly, B.; Grilli, M.; Brorson, B.; Schwartz, R.; Lenardo, M.J. 1992: Interleukin 2 gene regulation in non transformed cd4 positive t lymphocyte clones. FASEB Journal 6(5): A1982
Hara, I.; Miyake, H.; Eto, H.; Arakawa, S.; Kamidono, S. 1996: Interleukin 2 gene transfer to mouse renal cell carcinoma cell line leads to tumor rejection in syngeneic host. Journal of Urology 155(5 Suppl): 652A
Summers, B.R.; Davis, W.L.; Rees, T.D. 1990: Interleukin 2 identified in saliva from patients with severe periodontal disease. Journal of Dental Research 69(Special Issue): 244
Edwards, M.J.; Schuschke, D.A.; Abney, D.L.; Miller, F.N. 1990: Interleukin 2 il 2 acutely increases macromolecular leakage from the microcirculation. Proceedings of the American Association for Cancer Research 31: 297
Jablons, D.; Bolton, E.; Mertins, S.; Rubin, M.; Pizzo, P.; Lotze, M.T. 1989: Interleukin 2 il 2 administration to cancer patients alters neutrophil f c r expression superoxide response and chemotaxis. Proceedings of the American Association for Cancer Research 30: 377
Moretta L.; Melioli G.; Sertoli M.R.; Mingari M.C.; Badellino F.; Percivale P.; Baldini E.; Civalleri D.; De Maria A.; Et Al 1989: Interleukin 2 il 2 and its potential role in oncology. Conte, P F , Et Al (Ed ) Monograph Series Of The European Organization For Research And Treatment Of Cancer (Eortc), Vol 20 Multimodal Treatment Of Ovarian Cancer; Symposium Xxi+329p Raven Press, Ltd : New York, New York, Usa Illus 301-306
Evans, G.; Linnekin, D.; Farrar, W. 1990: Interleukin 2 il 2 and phytohemagglutinin pha stimulated phosphorylation of the retinoblastoma susceptibility gene product p110 115r b and the nuclear serine kinase p34c d c 2. FASEB Journal 4(7): A2083
D.L.M.rena M.; Carr, C.; Sher, M.; Day, N.K.; Good, R.A. 1992: Interleukin 2 il 2 il 2 receptor il 2r levels and il 2 production in pediatric patients with scleroderma. Journal of Allergy and Clinical Immunology 89(1 Part 2): 253
Moss, R.B.; Ohkubo, K.; Paciotti, G.; Tamarkin, L.; Hahn, B.; Igarashi, Y.; Hohman, R.; Kaliner, M.A. 1992: Interleukin 2 il 2 immunoreactivity in nasal mucosa. Journal of Allergy and Clinical Immunology 89(1 Part 2): 179
Lapchak, P.A.; Araujo, D.M.; Chabot J G.; Beaudet, A.; Quirion, R. 1989: Interleukin 2 il 2 in the rat brain receptors and immunoreactivity ir. Society for Neuroscience Abstracts 15(1): 836
Mulvin, D.W.; Grosso, M.A.; Kruse, C.A.; Repine, J.E.; Johnston, M.R. 1989: Interleukin 2 il 2 increases pulmonary capillary permeability via blood borne toxic oxygen metabolites. FASEB Journal 3(3): A316
Lapchak, P.A. 1991: Interleukin 2 il 2 increases tritiated dopamine release from rat striatal slices correlation with the presence of endogenous il 2 il 2 receptors and il 2 mrna in the rat striatum. Society for Neuroscience Abstracts 17(1-2): 1199
Kuziel, W.A.; Arima, N.; Grdina, T.A.; Fung, M.R.; Greene, W.C. 1991: Interleukin 2 il 2 induced growth signaling through the human interleukin 2 receptor il 2r activates nuclear expression of nf kappa b. Clinical Research 39(2): 314A
Boggs S.S.; Vecchini F.; Lu L.; Ildstad S.T.; Deleo A. 1991: Interleukin 2 il 2 induced natural killer nk activity and enrichment is increased in mouse long term bone marrow cultures ltbmc by t cell depletion using rabbit anti mouse brain serum rambs and complement. Experimental Hematology 19(6): 498
Helfand, S.C.; Modiano, J.F.; Nowell, P.C. 1990: Interleukin 2 il 2 infusion in the dog induces a response in il 2 target cells. Journal of Cellular Biochemistry Suppl (14 Part B): 97
Araujo, D.M.; Lapchak, P.A.; Beaudet, A.; Quirion, R. 1990: Interleukin 2 il 2 inhibits acetylcholine release from rat hippocampal slices by altering opioid peptide release. Society for Neuroscience Abstracts 16(2): 1213
Taniguchi, K.; Fukuo, K.; Morimoto, S.; Yanagisawa, M.; Masaki, T.; Suzuki, N.; Ogihara, T. 1991: Interleukin 2 il 2 inhibits endothelin 1 et 1 secretion from endothelial cells. Hypertension 18(3): 389
Andriole, G.L.; Yuan, J.J.J.; Ratliff, T.L. 1990: Interleukin 2 il 2 is detectable locally regionally and systematically after intravesical instillation in murine bladder. Journal of Urology 143(4 Suppl): 310A
X.W.; Leroy, E.C.; Smith, E.A. 1991: Interleukin 2 il 2 is mitogenic and fibrogenic for human fibroblasts fb. Journal of Cell Biology 115(3 Part 2): 422A
Kilbourn, R.; Owen Schaub, L.; Griffith, O.; Logothetis, C. 1992: Interleukin 2 il 2 mediated hypotension in dogs is reversed by n g methyl l arginine nma an inhibitor of nitric oxide formation. Proceedings of the American Association for Cancer Research 33: 328
Eleazar, M.S.; Zakarian, S. 1990: Interleukin 2 il 2 modulates processing of proopiomelanocortin pomc in the pars intermedia of the pituitary to activate beta endorphin. Van Ree, J M , Et Al (Ed ) International Congress Series, No 914 New Leads in Opioid Research; International Narcotics Research Conference, Noordwijkerhout, Netherlands, July 8-13, Xxvii+391p Elsevier Science Publishers B V (Biomedical Division): Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York) Illus 380-382
Wagerle, L.C.; Kim, S.J.; Cortey, A. 1991: Interleukin 2 il 2 priming modifies cerebral microvascular reactivity to carbon dioxide and platelet activating factor paf in newborn pigs. Pediatric Research 29(4 Part 2): 365A
Gengozian, N.; Hill, B.; Good, R.A.; Day, N.K. 1989: Interleukin 2 il 2 production by cat lymphocytes a positive role for guinea pig erythrocyte gpe rosetting cells. FASEB Journal 3(3): A319
Cox, D.S.; Davis, W.; Miller, C. 1989: Interleukin 2 il 2 receptor on cd8 positive and natural killer cells in periodontal disease. Journal of Dental Research 68(Special Issue): 1021
Tumbarello, M.; Citterio, F.; Cauda, R.; Pozzetto, U.; Caldarola, G.; Castagneto, M.; Ortona, L. 1991: Interleukin 2 il 2 reconstitutes natural killer nk cell activity in immunocompromised patients. Giornale di Malattie Infettive e Parassitarie 43(12): 1087-1091
Bonak, V.A.; Huang C K.; Wong, R.L.; Zhao, Y.F.; Clark, R.B.; Casnellie, J.E. 1989: Interleukin 2 il 2 regulated protein phosphorylation in helper t lymphocytes. FASEB Journal 3(4): A1133
Hornung, N.; Raskova, J.; Raska, K.Jr; Degiannis, D. 1990: Interleukin 2 il 2 responsiveness of human lymphocytes effect of cyclosporine a cya and prednisolone pred. FASEB Journal 4(4): A1022
Brown, D.; Redd, J.; Burgesser, K.; Stone, B.; Stone, G. 1989: Interleukin 2 il 2 reversible tumor produced immunosuppression is not due to competition for high affinity binding sites. FASEB Journal 3(4): A1134
Klasa, R.J.; Silver, H.K.B. 1989: Interleukin 2 il 2 splenic artery perfusion in advanced malignancy in vivo lymphokine activated killer lak cell generation and dose effect analysis. Proceedings of the American Association for Cancer Research 30: 371
Hanna, W.; Skosey, J.L.; Froelich, C.J. 1989: Interleukin 2 il 2 stimulated human lymphocytes degrade the extracellular matrix of rabbit chondrocyte monolayers. Arthritis and Rheumatism 32(4 Suppl): S133
Vander Hamm, D.; Evans Shields, J.; Laird, H.II 1992: Interleukin 2 il 2 stimulated lymphocyte proliferation a possible role for prolactin prl. FASEB Journal 6(5): A1877
Devens, B.H.; Kelley, M.; Terajima, C.; Webb, D.R. 1992: Interleukin 2 il 2 stimulates non specific suppressor cell activity. FASEB Journal 6(5): A1604
Westenfelder, C.; Hibbs, J.B.Jr; Ward, J.H.; Kablitz, C.; Baranowski, R.L.; Vavrin, Z.; Taintor, R.R.; Samlowski, W.E. 1991: Interleukin 2 il 2 therapy in patients raises serum nitrate levels as a consequence of enhanced nitric oxide synthesis from l arginine. Journal of the American Society of Nephrology 2(3): 514
Moody, D.B.; Isaacs, W.B. 1991: Interleukin 2 il 2 transfected prostate cancer cells generate systemic anti tumor effect. Proceedings of the American Association for Cancer Research 32: 247
Gisselbrecht, C.; Maraninchi, D.; Pico, J.L.; Milpied, N.; Coiffier, B.; Divine, M.; Tiberghien, P.; Bosly, A.; Tilly, H.; Souteyrand, P.; Brandely, M. 1992: Interleukin 2 il2 in lymphoma a phase ii multicentric study. Proceedings of the American Association for Cancer Research 33: 227
Foa, R.; Meloni, G.; Guarini, A.; Vignetti, M.; Marchis, D.; Tosti, S.; Tos, A.G.; Vischia, F.; Mandelli, F.; Gavosto, F. 1992: Interleukin 2 (IL2) in the management of acute myeloid leukemia: clinical and biological findings. Leukemia 6(Suppl 3): 115s-116s
Turner, B.C.; Hiedecker, G.; Rapp, U.; Reed, J.C. 1990: Interleukin 2 il2 induces phosphorylation and activation of p68 74 raf kinase in t lymphocytes. Journal of Cellular Biochemistry Suppl (14 Part B): 266
Latham, P.S.; Cox, G.W.; Pilaro, A.M.; Varesio, L. 1991: Interleukin 2 il2 induces tumoricidal activity in rat kupffer cells that express constitutive il2 receptor il2r. Journal of Cellular Biochemistry Suppl (15 Part F): 74
Dilloo, D.; Hanenberg, H.; Burdach, S. 1992: Interleukin 2 il2 inhibits clonogenic growth of the leukemic cell line k562 via the il2 receptor alpha. Experimental Hematology (Charlottesville) 20(6): 757
Escalante, A.; Stohl, W.; Horwitz, D.A. 1989: Interleukin 2 il2 production in family members of sle patients. Arthritis and Rheumatism 32(4 Suppl): S25
Heys, S.D.; Deehan, D.J.; Eremin, O. 1994: Interleukin 2 in clinical practice. EOS-Rivista di Immunologia ed Immunofarmacologia 14(1): 24-33
Teppler, H.; Cameron, P.; Kaplan, G.; Cohn, Z.A. 1991: Interleukin 2 in hiv infection safety and systemic effect of low dose intradermal administration. Clinical Research 39(2): 314A
Rankin, E.M. 1990: Interleukin 2 in man. Anticancer Research 10(5 Part B): 1452
Foa, R. 1996: Interleukin 2 in the management of acute leukaemia. British Journal of Haematology 92(1): 1-8
Foà, R.; Meloni, G.; Guarini, A.; Vignetti, M.; Mandelli, F.; Gavosto, F. 1992: Interleukin 2 in the management of hematologic malignancies. Pharmacological Research 26(Suppl 2): 82-83
Rowley, K.H.M.; Mort, D.; Keen, C.W.; Matthews, P.N.; Mason, M.D. 1996: Interleukin 2 in the treatment of metastatic renal cell carcinoma-durable complete response with long term follow-up. British Journal of Cancer 74(Suppl 28): 30
Wencel, M.L.; Shapiro, S.L.; Davis, G.S. 1990: Interleukin 2 increases the susceptibility of isolated rat lungs to neutrophil mediated injury. Clinical Research 38(2): 327A
Itoh, K.; Von Eschenbach, A.C.; Kim T Y.; Platsoucas, C.D.; Balch, C.M. 1989: Interleukin 2 induced activation and clonal analysis of tumor infiltrating lymphocytes of renal cell carcinoma. Journal of Urology 141(4 Part 2): 279A
Byrne, J.; Barry, K.; Gough, D.; Horgan, P.G.; Hanrahan, L.; Given, H.F. 1991: Interleukin 2 induced growth suppression of oestrogen dependent breast tumour growth. European Journal of Cancer 27(Suppl 3): S26
Schwarz, R.E.; Hiserodt, J.C. 1990: Interleukin 2 induced specific antitumor immunity is organ dependent. FASEB Journal 4(3): A479
Zeilender, S.; Fairman, P.; Davis, D.; Jesmok, G.; Glauser, F. 1989: Interleukin 2 induced systemic hypotension reversibility with inotropic and vasoactive drugs. Clinical Research 37(1): 10A
Anderson, T.D.; Valentine, T.; Lucas, D.; Becker, J.; Durham, S.K.; Gately, M.K.; Hayes, T.J. 1989: Interleukin 2 induced vascular leak syndrome in mice is secondary to endothelial cytotoxicity mediated by lymphokine activated killer lak cells. Laboratory Investigation 60(1): 3A
Heilig, B.; Benenson, E.; Roehlig, C.; Goette, B.; Diehl, V. 1998: Interleukin 2 induces apoptosis of synovial lymphocytes in patients with rheumatoid arthritis. Arthritis and Rheumatism 41(9 Suppl): S277
Brockdorff, J.; Svejgaard, A.; Odum, N. 1996: Interleukin 2 induces downregulation of protein phosphatase 2A activity in human CD4+ T cell lines. Scandinavian Journal of Immunology 43(6): 697
Winterrowd, G.E.; Fleming, W.E.; Krzeskicki, R.F.; Nickoloff, B.J.; Chin, J.E.; Sanders, M.E. 1990: Interleukin 2 induces expression of memory phenotype markers and enhances adhesion of cd45ra positive and cd29 positive t cell subsets. FASEB Journal 4(7): A2186
Augustine, J.A.; Sutor, S.L.; Leibson, P.J.; Abraham, R.T. 1991: Interleukin 2 induces phosphatidylinositol 3 kinase activity in t lymphocytes. FASEB Journal 5(4): A424
Maslinski, W.; Remillard, B.; Hadro, E.; Strom, T.B. 1991: Interleukin 2 induces translocation of active serine threonine kinase raf 1 from il 2 receptor beta chain to cytosol. Journal of Cell Biology 115(3 Part 2): 273A
Gottlieb, D.J.; Prentice, H.G.; Brenner, M.K. 1990: Interleukin 2 infusion abrogates humoral immune responses. British Journal of Haematology 74(Suppl 1): 22
Heslop, H.E.; Duncombe, A.S.; Reittie, J.E.; Bello Fernandez, C.; Gottlieb, D.J.; Prentice, H.G.; Mehta, A.B.; Hoffbrand, A.V.; Brenner, M.K. 1990: Interleukin 2 infusion induces hemopoietic growth factors and modifies marrow regeneration. British Journal of Haematology 74(Suppl 1): 2
Heslop, H.E.; Bello Fernandez, C.; Duncombe, A.S.; Oblakowski, P.; Reitie, J.; Hoffbrand, A.V.; Prentice, H.G.; Brenner, M.K. 1990: Interleukin 2 infusions in patients with hematological malignancy in partial or complete remission. Bone Marrow Transplantation 5(Suppl 2): 26
Fleischmann, J.; Acino, S. 1989: Interleukin 2 inhibitor activity in urine during cystitis will predict the likelihood of cystitis recurrence. Journal of Urology 141(4 Part 2): 363A
Nowak, R.; Erich, A.C.; Kleemann, D.; Friemel, H.; Loebe, P.; Schock, J. 1989: Interleukin 2 inhibitory activity in the serum of ent patients with different diseases. Archives of Oto-Rhino-Laryngology 246(6): 458
Y.S.L.; Istfan, N.W.; Bistrian, B.R. 1992: Interleukin 2 inhibits tumor growth and alters protein kinetics in the tumor bearing rat. FASEB Journal 6(5): A1965
Chopra, R.K.; Nagel, J.E.; Powers, D.C.; Adler, W.H. 1989: Interleukin 2 interleukin 2 receptor and interferon gamma gene expression by t cells of the elderly humans. FASEB Journal 3(3): A781
Harfmann, P.; Dittmer, R.; Tenschert, W.; Meyer Moldenhauer W H.; Arndt, R.; Klosterhalfen, H. 1991: Interleukin 2 interleukin 4 interleukin 6 and interleukin 2 receptor levels for noninvasive monitoring after renal transplantation. Journal of Urology 145(4 Suppl): 306A
Maghazachi, A.A. 1990: Interleukin 2 is central for the development of rat lak cells regulation by various cytokines. Schmidt, R E (Ed ) Natural Killer Cells: Biology And Clinical Application; 6th International Natural Killer Cell Workshop, Goslar, Germany, July 26-29, 1989 Xii+318p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 190-193
Metwali, A.; Blum, A.; Mathew, R.; Elliott, D.; Weinstock, J. 1993: Interleukin 2 is necessary for interleukin 5 production in granulomas. Gastroenterology 104(4 Suppl): A743
Pilon, M.; Williams Miller, C.; Cox, D.S. 1991: Interleukin 2 levels in gingival crevicular fluid in periodontitis. Journal of Dental Research 70(Special Issue): 550
Murthy K.K.; Bhandaru S.; Ali M.; Tu L.; Wolfson K.; Kumar P. 1990: Interleukin 2 levels in patients with allergy asthma. Journal of Allergy and Clinical Immunology 85(1 Part 2): 270
Anderson, P.M.; Leonard, A.S.; Nesbit, M.; Ochoa, A.C. 1989: Interleukin 2 liposomes for pulmonary metastases local intrathoracic route and liposome formulation have superior anticancer effects. Proceedings of the American Association for Cancer Research 30: 365
Davidovitch, Z.; Lynch, P.; Shanfeld, J.L. 1989: Interleukin 2 localization in the mechanically stressed periodontal ligament. Journal of Dental Research 68(Special Issue): 333
Stevens, A.C.; Lipman, M.; Spivack, J.; Peppercorn, M.A.; Strom, T.B. 1994: Interleukin 2 mRNA transcript levels do not differ among ulcerative colitis and normal colonic specimens. Clinical Research 42(2): 134A
Devens, B.H.; Terajima, C.; Koontz, A.W.; Kelly, M.; Webb, D.R. 1990: Interleukin 2 mediated down regulation of cell mediated immune responses in vitro. Lymphokine Research 9(4): 566
Bill, O.; Garlisi, C.G.; Mastro, A.M. 1991: Interleukin 2 mrna levels and half life vary with the mode of mitogenic stimulation of lymphocytes. Journal of Cell Biology 115(3 Part 2): 428A
Negrier, S.; Mercatello, A.; Facrot, M.; Palmer, P.; Bret, M.; Kaemmerlen, P.; Franks, C.; Philip, T. 1990: Interleukin 2 or interleukin 2 and interferon in renal cell carcinoma a summary report of 2 years. Natural Immunity and Cell Growth Regulation 9(2): 66-67
Rottschafer, S.; Bosco, M.C.; Ortaldo, J.; Espinza Delgado, I. 1997: Interleukin 2 plus interferon gamma induce interleukin 12 mRNA expression and protein secretion. Proceedings of the American Association for Cancer Research 38: 303
Stein, A.; O'donnell, M.R.; Parker, P.; Snyder, D.S.; Nademanee, A.; Krishnan, A.; Kashyap, A.; Molina, A.; Rodriguez, R.; Spielberger, R.; Fung, H.C.; Bhatia, R.; Wong, K.K.; Niland, J.; Slovak, M.; Vora, N.; Sniecinski, I.; Dagis, A.; Arbayo, C.; Woo, D.; Forman, S.J. 1998: Interleukin 2 post high dose cytarabine mobilized autologous stem cell transplant for adult patients with acute myelogenous leukemia in first complete remission. Blood 92(10 Suppl 1 Part 1-2): 292A
Kruse, A.; Rink, L.; Neustock, P.; Kirchner, H. 1991: Interleukin 2 production and interleukin 2 receptor expression by human cord blood cells. Immunobiology 183(3-4): 229
Helyar, L.; Sherman, A.R. 1989: Interleukin 2 production and responsiveness by rat leukocytes during iron deficiency. FASEB Journal 3(3): A665
Roilides, E.; Clerici, M.; Depalma, L.; Rubin, M.; Pizzo, P.A.; Shearer, G. 1990: Interleukin 2 production by t helper cells from hiv infected children in response to hla self restricted or hla allo restricted antigens. FASEB Journal 4(3): A492
Gutierrez, C.; Cabrero, E.; Vicario, J.L.; Martín Villa, M.; Rengel, M.A.; Gomez Campdera, F.J.; Yebra, M.; Fernández-Cruz, E.; Arnaiz Villena, A. 1991: Interleukin 2 production in a family with systemic lupus erythematosus and a C4Q0 heterozygous inheritance. Annals of the Rheumatic Diseases 50(8): 579-582
Denton, G.W.L.; Robbins, R.A.; Durrant, L.G.; Austin, E.B.; Hardcastle, J.D.; Baldwin, R.W. 1991: Interleukin 2 production in patients with advanced colorectal carcinoma immunised with a human anti idiotypic monoclonal antibody. Gut 32(10): A1204
Lei C M.; Qin Yuezheng; Meng P L.; Xu Y E. 1990: Interleukin 2 production of human marrow cells increased significantly after cryopreservation. Cryobiology 27(6): 627
Clerici, M.; Stocks, N.I.; Zajac, R.A.; Boswell, R.N.; Bernstein, D.C.; Mann, D.L.; Shearer, G.M.; Berzofsky, J.A. 1989: Interleukin 2 production used to detect antigenic peptide recognition by t helper lymphocytes from asymptomatic hiv seropositive individuals. Nature (London) 339(6223): 383-385
Reed, W.A.; White, K.L.; Enright, F.M.; Jaynes, J.M. 1996: Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice. Abstracts of the General Meeting of the American Society for Microbiology 96: 274
Dittel, B.N.; Landay, A.L.; Bray, R.A. 1989: Interleukin 2 promotes the loss of nk and adcc function following in vitro culture with hiv. FASEB Journal 3(3): A819
Ciardelli, T.; Smith, K.A. 1989: Interleukin 2: prototype for a new generation of immunoactive pharmaceuticals. Trends in Pharmacological Sciences 10(6): 239-243
Van Sickler, J.T.; Pickard, L.L.; Salomon, D.R. 1990: Interleukin 2 provides in important signal for maintenance of allospecific cd8 positive suppressor cells. Kidney International 37(1): 601
Myers, T.J.; Lillehoj, H.; Fetterer, R. 1991: Interleukin 2 purification from chicken splenocyte conditioned media. Poultry Science 70(Suppl 1): 86
Honjo, T.; Shimizu, A. 1989: Interleukin 2 receptor and a method for production thereof us patent 4816565 march 28 1989. Official Gazette of the United States Patent and Trademark Office Patents 1100(4): 2452
Waldmann, T.A.; Leonard, W.J. 1998: Interleukin 2 receptor and applications thereof. Official Gazette of the United States Patent and Trademark Office Patents 1216(2): 1705
Kimura, T.; Toshida, H.; Tachibana, N.; Fujimaki, T.; Hotta, Y.; Kanai, A.; Nakamura, S.; Suhadolnik, R.J. 1996: Interleukin 2 receptor and interferon induction on ocular epithelium by double-stranded RNA. IOVS Investigative Ophthalmology and Visual Science 37(3): S860
Merida, I.; Gaulton, G.N. 1990: Interleukin 2 receptor associated tyrosine kinase. Journal of Cellular Biochemistry Suppl (14 Part B): 278
Minamoto, S.; Hatakeyama, M.; Kono, T.; Doi, T.; Mori, H.; Tsudo, M.; Miyata, T.; Miyasaka, M.; Taniguchi, T. 1989: Interleukin 2 receptor beta chain complementary dna cloning characterization of the complementary dna product expressed in mammalian cells. Cell Structure and Function 14(6): 863
Taniguchi, T.; Hatakeyama, M.; Minamoto, S.; Kono, T.; Doi, T.; Tsudo, M.; Miyasaka, M.; Miyata, T. 1989: Interleukin 2 receptor beta chain molecular cloning and functional expression of the human complementary dna. Cold Spring Harbor Laboratory Cold Spring Harbor Symposia on Quantitative Biology, Vol 54 Nos 1 And 2 Immunological Recognition Xix+603p (No 1); Xi+pagination Varies(No 2) Cold Spring Harbor Laboratory Press: Cold Spring Harbor, New York, Usa Illus 689-694
Herndon, B.L.; O'toole, L.; Reisz, G.; Willsie, S.; Marinac, J.; Dew, M. 1996: Interleukin 2 receptor decrease on dopamine infusion in man. FASEB Journal 10(6): A1448
Waldmann, T.A.; Junghans, R.P. 1990: Interleukin 2 receptor directed therapy a model for immune intervention. AIDS Research and Human Retroviruses 6(1): 96
Kupiec-Weglinski, J.W.; van der Meide, P.; Stunkel, K.G.; Tanaka, K.; Diamantstein, T.; Tilney, N.L. 1989: Interleukin 2 receptor directed therapy in rat recipients of cardiac allografts: synergistic and antagonistic interactions with the gamma interferon network. Transplantation Proceedings 21(1 Part 1): 992-993
Chen, H.P.; Zhu, H.; Li, L.S. 1996: Interleukin 2 receptor expression in human kidney allografts an its clinical significance. Nephrology Dialysis Transplantation 11(6): A285
Orson, F.M.; Saadeh, C.S.; Lewis, D.E.; Nelson, D.L. 1989: Interleukin 2 receptor expression in t cells from the aged. FASEB Journal 3(4): A1131
Matusiewicz, S.P.; Wallace, W.A.H.; Cossar, D.; Howie, S.E.M.; Greening, A.P. 1993: Interleukin 2 receptor expression is increased on peripheral blood lymphocytes in patients with moderate to severe symptomatic asthma. Thorax 48(10): 1080
Noronha, I.L.; Pomer, S.; Daniel, V.; Rambausek, M.; Staehler, G. 1990: Interleukin 2 receptor il 2r and tumor necrosis factor tnf plasma levels for differential diagnosis of renal allograft rejection. Journal of Urology 143(4 Suppl): 286A
Azzarone, B.; Rubinstein, E.; Benoit, P.; Jasmin, C.; Smith, H.; Stern, R. 1989: Interleukin 2 receptor il2 r chains are differentially expressed by human skin and stromal fibroblasts of the mammary gland. Breast Cancer Research and Treatment 14(1): 174
Benezra, D.; Barak, V.; Kalichman, I.; Maftzir, G. 1991: Interleukin 2 receptor in behcets disease effect of cyclosporin a. IOVS Investigative Ophthalmology and Visual Science 32(4): 935
Cox, D.S.; Songho, O.; Choi, M. 1992: Interleukin 2 receptor in gingival crevicular fluid in periodontitis. Journal of Dental Research 71(Special Issue): 575
Bouchot, O.; Anegon, I.; Romaniuk, A.; Jacques, Y.; Soulillou, J.P. 1990: Interleukin 2 receptor in rat allograft rejection. Transplantation Proceedings 22(4): 1995-1997
Spear, M.L.; Stefano, J.L.; Fawcett, P.; Proujansky, R. 1991: Interleukin 2 receptor levels in premature neonates. Pediatric Research 29(4 Part 2): 235A
Otero, G.; Merrill, J.E. 1991: Interleukin 2 receptor like proteins on a human oligodendroglioma subclone. Journal of Neurochemistry 57(Suppl): S30
Oringer, R.; Williams Miller, C.; Cox, D.S. 1991: Interleukin 2 receptor on natural killer and cd8 positive gingival cells in periodontitis. Journal of Dental Research 70(Special Issue): 550
Yoshie, H.; Takeuchi, Y.; Ofuji, Y.; Yamazaki, K.; Hara, K. 1989: Interleukin 2 receptor positive gingival lymphocytes in periodontal patients. Journal of Dental Research 68(Special Issue): 1021
Gangal, S.G.; Damle, R.N.; Advani, S.H.; Tatake, R.J. 1990: Interleukin 2 receptor status and post ligand receptor binding events in activated lymphocytes from hodgkins disease hd. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 286
Lemaistre, C.F.; Mccaffrey, R.; Woodworth, T.; Strom, T.B.; Nichols, J.C.; Murphy, J.R. 1992: Interleukin 2 receptor targeted cytotoxic therapy phase i clinical studies of dab 486 il 2 fusion toxin in hematologic malignancies. Witholt, B , Et Al (Ed ) Zentralblatt Fuer Bakteriologie Suppl, 23; (International Journal Of Medical Microbiology Suppl, 23) Bacterial Protein Toxins; Fifth European Workshop, Veldhoven, Netherlands, June 30-July 5, 1991 Xiv+513p Gustav Fischer Verlag: Stuttgart, Germany; New York, New York, Usa Illus 395-404
Diamantstein, T.; Volk H D.; Hahn, H.J.; Tilney, N.L.; Kupiec Weglinski, J.W. 1989: Interleukin 2 receptor targeted immunotherapy update and attempt at synthesis. Melchers, F (Ed ) Progress in Immunology, Vol Vii; 7th International Congress Of Immunology, Berlin, West Germany, Ci+1318p Springer-Verlag New York, Inc : Secaucus, New Jersey, Usa; Berlin, West Germany Illus 619-626
Murphy, J.R.; Waters, C.; Schimke, P.; Strom, T.B. 1989: Interleukin 2 receptor targeted toxicity il 2 receptor requirements for the action of il 2 toxin. Abstracts of Papers American Chemical Society 198: MBTD 138
Allouche, M.; Sahraoui, Y.; Augery-Bourget, Y.; Perrakis, M.; Jasmin, C.; Georgoulias, V. 1990: Interleukin 2 receptors. Leukemia Research 14(8): 699-703
Spear, M.L.; Stefano, J.L.; Fawcett, P.; Proujansky, R. 1991: Interleukin 2 receptors in premature neonates with sepsis. Pediatric Research 29(4 Part 2): 287A
Sacchi, M.; Heo, D.S.; Dahl, C.; Johnson, J.T.; Herberman, R.B.; Whiteside, T.L. 1990: Interleukin 2 receptors on human squamous cell carcinoma lines. Proceedings of the American Association for Cancer Research 31: 52
Waldmann, T.A. 1990: Interleukin 2 receptors targets for immune intervention in leukemia. Proceedings of the American Association for Cancer Research 31: 498-499
Zona, C.; Palma, W.; Santoni, A.; Grassi, F.; Eusebi, F. 1990: Interleukin 2 reduces voltage activated sodium currents in embryonic rat hippocampal neurons. Society for Neuroscience Abstracts 16(1): 181
Inokuchi, S.; Toda, T.Y.; Imboden, J.B. 1991: Interleukin 2 regulates phosphatidylinositol 3 kinase in human peripheral t lymphocytes. Journal of the American Society of Nephrology 2(3): 546
Farrar, W.L.; Linnekin, D.; Evans, G.; Garcia Garcia, G.; Michiel, D. 1990: Interleukin 2 regulation of a tyrosine kinase associated with the p70 75 beta chain of the receptor complex. Oppenheim, J J , Et Al (Ed ) Progress in Leukocyte Biology, Vol 10a Molecular And Cellular Biology Of Cytokines; Second International Workshop on Cytokines, Hilton Head Island, South Carolina, Usa, December 10-14, 1989 Xli+570p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 265-270
Lefever, A.; Funahashi, A. 1990: Interleukin 2 reversal of alveolar macrophage inhibition of lymphokine activated killer cell generation. American Review of Respiratory Disease 141(4 Part 2): A56
Roellinghoff, M. 1990: Interleukin 2 review of current knowledge. Natural Immunity and Cell Growth Regulation 9(2): 62
Thaiss, F.; Bergmann, L.; Hahatsch, M.J.; Schoeppe, W.; Stahl, R.A.K. 1990: Interleukin 2 ril 2 aggravates glomerular injury in a model of in situ immune complex glomerulonephritis icgn in rats. Natural Immunity and Cell Growth Regulation 9(2): 74-75
Fish, R.G.; Keen, C.W.; Shelley, M.D.; Mort, D.; Franks, C.R. 1992: Interleukin 2 ril 2 therapy for renal cell cancer rcc correlation between clinical response survival and serum levels of tnf il 1 il 6 and c reactive protein crp. Proceedings of the American Association for Cancer Research 33: 347
Limouris, G.S.; Constantoulakis, E.M.; Limouri Fetsi, J.C.; Shukla, S.K.; Shomaeker, K. 1990: Interleukin 2 serum levels in prostate and breast cancer. Anticancer Research 10(5 Part B): 1440
Cannao, G.; Condorelli, A.; Piazza, B. 1989: Interleukin 2 serum levels on seven patients with arc aids personal casuistry. Giornale di Malattie Infettive e Parassitarie 41(9): 931-932
Hamblin, T.J. 1990: Interleukin 2 side effects are acceptable. British Medical Journal 300(6720): 275-276
Testa I.; Cavarape A.; Bottaccio A.; Bartolotta E.; Recchioni A.; De Sio G.; Fumelli P. 1990: Interleukin 2 soluble interleukin 2 receptors and insulin autoantibodies in newly diagnosed type 1 diabetic patients. Diabetologia 33(Suppl): A25
Hanna, W.L.; Skosey, J.L.; Froelich, C.J. 1989: Interleukin 2 stimulated human lymphocytes contain proteases which degrade cartilage proteoglycans. Clinical Research 37(4): 905A
Garritsen H.S.P.; Pelzer P.; Kuhlmann M.; Woermann B.; Doorbos R.; Buechter U.; Buechner T.; De Grooth B.G.; Greve J.; Hiddemann W. 1991: Interleukin 2 stimulated nk cells and t cell subsets inhibit colony formation of autologous leukemic blasts in aml. Proceedings of the American Association for Cancer Research 32: 238
Jiang, C.Y.; Zhang, M.W.; Jiang, F.Z.; Mao, N.; Tang, P.H. 1992: Interleukin 2 stimulated t cell clones selectively inhibit the colony formation of leukemia stem cells in man. Experimental Hematology (Charlottesville) 20(6): 820
Schell, S.; Novak, K.; Torre, G.; Fitch, F. 1989: Interleukin 2 stimulates gm csf production in murine helper t cell clones through an antigen independent pathway. FASEB Journal 3(4): A1269
L.Z.Y. 1990: Interleukin 2 suppressed tritiated ohmefentanyl and tritiated dadle binding to rat brain opioid receptors. Society for Neuroscience Abstracts 16(1): 369
Macdonald, D.; Jiang, Y.Z.J.; Kajitani, H.; Gordon, A.; Caravita, T.; Barrett, A.J. 1990: Interleukin 2 therapy associated eosinophilia is mediated via interleukin 5 production. British Journal of Haematology 74(Suppl 1): 2
Cortes, J.; Kantarjian, H.; O'brien, S.; Keating, M.; Estey, E. 1997: Interleukin 2 therapy for adult patients with acute myelogenous leukemia in first complete remission. Blood 90(10 Suppl 1 Pt 1): 505A
Fleischmann, J.D.; Kim, B. 1990: Interleukin 2 therapy for renal cell carcinoma case reports of primary lesion response and planned delayed nephrectomy. Journal of Urology 143(4 Suppl): 319A
Parkinson, D.R. 1991: Interleukin 2 therapy in renal cell carcinoma and malignant melanoma. Cancer Bulletin 43(2): 96-99
Stuntz, M.; Champsi, J.; Witte, M.; Way, D.; Witte, C.; Finley, P.; Gschwind, C.; Hersh, E. 1989: Interleukin 2 therapy increases capillary filtering surface area rather than permeability in the rat intestine. Clinical Research 37(2): 420A
Fish, R.B.; Keen, C.W.; Shelley, M.D.; Mort, D.; Franks, C.R. 1991: Interleukin 2 therapy unusual pharmacokinetics during continuous 5 day iv infusion in cancer patients. British Journal of Cancer 64(Suppl 15): 4
Morse, E.D.; Hughes, K.S.; Jesmok, G.; Gunther, R.A. 1989: Interleukin 2 toxicity is reduced by steroid pretreatment in sheep. FASEB Journal 3(3): A831
Tiberghien, P.; Racadot, E.; Delain, M.; Voillat, L.; Billod, M.; Deschaseaux, M.; Cahn, J.Y.; Flesch, M.; Herve, P. 1990: Interleukin 2 treatment of a b cell lymphocytic lymphoma reversible increase of the b cell monoclonal lymphocytosis. Experimental Hematology 18(6): 649
Jacques, Y.; Breathnach, R.; Vie, H.; Bonneville, M.; Gesnel M C.; Peyrat M A.; Godard, A.; Soulillou J P. 1991: Interleukin 2 truncated human igm heavy chain fusion protein a cytotoxic agent for interleukin 2 receptor bearing cells. Cytokine 3(5): 490
Sartori, M.L.; Masera, R.G.; Staurenghi, A.; Bisbocci, D.; Mestrurino, E.; Angeli, A. 1997: Interleukin 2 up-regulates in vitro glucocorticoid receptors in human peripheral blood mononuclear cells and osteosarcoma cell line SaOS2. Steroids 62(11): 738
Jaspert, B.; Hartmann, K.U. 1993: Interleukin 2- and interleukin 2 receptor-mRNA expression in stimulated lymphoid tissue. Immunobiology 189(1-2): 85
Lovik, G.; Vaage, J.T.; Naper, C.; Rolstad, B. 1992: Interleukin 2-producing cells grown in diffusion chambers in the peritoneal cavity of nude rats Effects on natural killer cells. Scandinavian Journal of Immunology 36(4): 634
Lorberboum Galski, Haya 1994: Interleukin 2-pseudomonas exotoxin A chimeric protein for targeted immunotherapy and the study of immune responses. Journal of Toxicology Toxin Reviews 13(1): 105-109
Pforte, A.; Brunner, B.; Beer, B.; Ziegler, H.W. 1994: Interleukin 2-receptor expression in different clinical forms of sarcoidosis. Tubercle and Lung Disease 75(Suppl 1): 101
Kretowski, A.; Mysliwiec, J.; Szelachowska, M.; Brzozowski, C.; Kinalska, I. 1998: Interleukin 2/IL-2 receptor system as a risk marker of type 1 diabetes mellitus development. Diabetologia 41(Suppl 1): A96
Fina, D.; Sarra, M.; Caruso, R.; Del Vecchio Blanco, G.; Pallone, F.; MacDonald, T.T.; Monteleone, G. 2008: Interleukin 21 contributes to the mucosal T helper cell type 1 response in coeliac disease. Gut 57(7): 887-892
Smyth, M.J.; Teng, M.W.L.; Sharkey, J.; Westwood, J.A.; Haynes, N.M.; Yagita, H.; Takeda, K.; Sivakumar, P.V.; Kershaw, M.H. 2008: Interleukin 21 enhances antibody-mediated tumor rejection. Cancer Research 68(8): 3019-3025
Stocking, C.; Ostertag, W. 1990: Interleukin 3 a multilineage hematopoietic growth factor. Habenicht, A (Ed ) Growth Factors, Differentiation Factors, And Cytokines Xvii+476p Springer-Verlag: Berlin, West Germany; New York, New York, Usa Illus 115-128
Kurzrock, R.; Talpaz, M.; Gutterman, J.U. 1992: Interleukin 3 a review. Talpaz, M , R Kurzrock And J U Gutterman (Ed ) Hematology (New York), Vol 15 Biological Response Modifiers in The Treatment Of Hematopoietic Neoplasia Xvii+274p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 209-223
Schrader, J.W.; Razin, E.; Ponting, I.; Leslie, K.; Welham, M. 1990: Interleukin 3 a role in interactions between stromal and hemopoietic cells. Lymphokine Research 9(4): 614
Ganser, A.; Ottmann, O.G.; Hoelzer, D. 1993: Interleukin 3 and interleukin 3/GM-CSF combination therapy--clinical implications. Stem Cells 11(6): 465-473
Razin, E.; Chaikin, E.; Daniel Issakani, S.; Strulovici, B. 1989: Interleukin 3 and interleukin 4 activate the phosphorylation of distinct sets of membrane proteins by protein kinase c in murine bone marrow derived mast cells relevance to biological role. FASEB Journal 3(3): A788
Takafuji S.; Bischoff S.C.; De Weck A.L.; Dahinden C.A. 1991: Interleukin 3 and interleukin 5 prime normal human eosinophils to produce leukotriene c4 in response to soluble agonists. FASEB Journal 5(4): A641
Saba, H.I.; Moffitt, H.L.e 1997: Interleukin 3 and newer hematopoietic growth factors in the management of myelodysplastic syndrome. Leukemia Research 21(Suppl 1): S40
Ferris, D.K.; Willette-Brown, J.; Martensen, T.; Farrar, W.L. 1989: Interleukin 3 and phorbol ester stimulate tyrosine phosphorylation of overlapping substrate proteins. Febs Letters 246(1-2): 153-158
Laskay, G.; Varhelyi, T.; Dale, R.E.; Dexter, T.M. 1992: Interleukin 3 associated ionic events in murine haemopoietic cells. Biophysical Journal 61(2 Part 2): A385
Oster, W.; Schulz, G. 1991: Interleukin 3: biological and clinical effects. International Journal of Cell Cloning 9(1): 5-23
Tafuri A.; De Felice L.; Meloni G.; De Gregoris C.; Fenu S.; Goodacre A.; Cedrone M.; Guglielmi G.; Burgio V.L.; Et Al 1992: Interleukin 3 chemotherapy treatment of acute myeloid leukemia in vivo and in vitro studies. Proceedings of the American Association for Cancer Research 33: 231
Hagenaars C.E.; V.D.Kraan A.A.M.; Kawilarang De Haas E.W.M.; Spooncer E.; Dexter T.M.; Nijweide P.J. 1990: Interleukin 3 dependent hemopoietic stem cell lines are capable of osteoclast formation in vitro a model system for the study on osteoclast formation. Cohn, D V , F H Glorieux And T J Martin (Ed ) International Congress Series, 886 Calcium Regulation And Bone Metabolism: Basic And Clinical Aspects; Proceedings Of The 10th International Conference on Calcium Regulating Hormones And Bone Metabolism, Montreal, Quebec, Canada, September 9-14, 1989 Xxi+533p Elsevier Science Publishers B V : Amsterdam, Netherlands; (Dist in The Usa And Canada By Elsevier Science Publishing Co , Inc : New York, New York) Illus 280-284
Crump, M.; Kovacs, M.J.; Zollinger, L.; Keating, A. 1991: Interleukin 3 for bone marrow failure after autologous bone marrow transplantation abmt. Clinical and Investigative Medicine 14(4 Suppl): A60
Crump, M.; Couture, F.; Kovacs, M.; Zollinger, L.; Mccrae, J.; Keating, A. 1992: Interleukin 3 for graft failure following autologous bone marrow transplantation for hematologic malignancies. Experimental Hematology (Charlottesville) 20(6): 772
Adshead, F.J.; Hickish, T.; Purvies, H.; Cunningham, D.; Smith, I.E.; Millar, J.L. 1991: Interleukin 3 gene expression in cycloprimed bone marrow. Experimental Hematology 19(6): 523
Guba, S.C.; Stella, G.; Turka, L.A.; June, C.H.; Thompson, C.B.; Emerson, S.G. 1989: Interleukin 3 gene induction in normal human t cells via stimulation of cd3 and cd28. Clinical Research 37(4): 902A
Saito, M.; Ohta, M.; Nakamura, M.; Tsunoda, A.; Kitagawa, S.; Hara, K. 1990: Interleukin 3 gene introduction into nfs 60 cells induces their autocrine growth tumorigenicity and simultaneous expression of tumor associated gangliosides. Experimental Hematology 18(6): 711
Young, C.E.; Mcilheran, S.M.; Vadhan Raj, S.; Williams, D.E.; Buescher, E.S. 1991: Interleukin 3 granulocyte macrophage colony stimulating factor fusion protein effects on human neutrophil function. Clinical Research 39(2): 445A
Van Gils, F.C.J.M.; Wielenga, J.J.; Van Den Bos, C.; Burger, H.; Heeney, J.L.; Wagemaker, G. 1991: Interleukin 3 hyperstimulation syndrome in rhesus monkeys. Experimental Hematology 19(6): 516
Ceribelli, A.; Fossati, C.; Gamucci, T.; Tritarelli, E.; Testa, U.; Peschle, C.; Sguotti, C.; Calabresi, F. 1992: Interleukin 3 il 3 by 120 hour continuous infusion ci after myelosuppressive chemotherapy ct a phase i study. Proceedings of the American Association for Cancer Research 33: 231
Ho J.L.; Reed S.G.; He S.H.; Arruda S.; Wick E.A.; Grabstein K. 1991: Interleukin 3 il 3 induces antimicrobial and tumoricidal activity. Clinical Research 39(2): 150A
Kittler, E.L.W.; Turner, B.L.; Crittenden, R.B.; Quesenberry, P.J. 1992: Interleukin 3 il 3 is a possible paracrine and or autocrine regulatory mechanism in murine bone marrow cultures. Experimental Hematology (Charlottesville) 20(6): 809
Rottem, M.; Metcalfe, D.D. 1992: Interleukin 3 il 3 is the only cytokine both necessary and sufficient for mast cell proliferation. Journal of Allergy and Clinical Immunology 89(1 Part 2): 240
Weinstein, T.; Fishman, P.; Djaldetti, M.; Levi, J. 1989: Interleukin 3 il 3 levels in uremic and dialysis patients. Kidney International 35(1): 375
Goeden, B.; Reinhold, U.; Kukel, S.; Neumann, U.; Kreysel H W. 1991: Interleukin 3 il 3 mediates proliferation of human pbmc and t lymphocytes. Cytokine 3(5): 462
Djeu, J.Y.; Wang, M.; Shiotsuki, K.; Blanchard, D.K. 1989: Interleukin 3 il3 enhancement and maintenance of function in human monocytes against candida albicans. Abstracts of the Annual Meeting of the American Society for Microbiology 89: 477
Bickel, M.; Pluznik, D.H. 1989: Interleukin 3 il3 is transcriptionally activated in murine t cells. Journal of Cellular Biochemistry Suppl (13 Part C): 34
Schneider E.; Lemoine F.; Ploemacher R.E.; Navarro S.; Ichikawa A.; Dy M. 1992: Interleukin 3 induced histamine synthesis by murine bone marrow progenitors evidence against the involvement of mast cells and their committed progenitors. Experimental Hematology (Charlottesville) 20(6): 765
Nowak, R.; Liebsch, M.; Oelschlaegel, U.; Range, U.; Gurth, H.; Hofmann, R.; Zengler, H.; Herbst, R.; Ehninger, G. 1998: Interleukin 3 induced in vitro growth of blasts as a marker for the clinical outcome in AML. Annals of Hematology 77(Suppl 2): S146
Galoforo, S.; Lum, L.G.; Joshi, I.D.; Smith, M.R. 1992: Interleukin 3 mrna is expressed by human marrow stromal cells. Experimental Hematology (Charlottesville) 20(6): 812
Askew, D.S.; Mano, H.; Weinstein, Y.; Isfort, R.; Cleveland, J.L.; Ihle, J.N. 1990: Interleukin 3 regulated growth and differentiation of hematopoietic stem cells. Romagnani, S And A K Abbas (Ed ) Serono Symposia Publications From Raven Press, Vol 68 Cytokines: Basic Principles And Clinical Applications; Meeting Xix+370p Raven Press: New York, New York, Usa Illus 291-302
Van Gils, F.C.J.M.; Burger, H.; Dorssers, L.C.J.; Van Leen, R.W.; Wielenga, J.J.; Heeney, J.L.; Knol, E.; Wagemaker, G. 1990: Interleukin 3 stimulates all major bone marrow derived blood cell lineages in rhesus monkeys. Experimental Hematology 18(6): 710
Banchereau, J. 1990: Interleukin 4. International Journal of Radiation Applications and Instrumentation. Part B Nuclear Medicine and Biology 17(7): 619-623
Navaux, F.; Lescoulie, P.L.; Constantin, A.; Mazieres, B.; Cantagrel, A. 1998: Interleukin 4 and interleukin 10 gene polymorphisms Relationship to occurrence and severity of rheumatoid arthritis. Arthritis and Rheumatism 41(9 Suppl): S64
Stevens, A.C.; Zheng, X.X.; Simpson, S.J.; Horak, I.; Strom, T.B. 1994: Interleukin 4 and interleukin 10 mRNA expression in the interleukin 2 deficient colitic mouse. Gastroenterology 106(4 Suppl): A778
Callard, R.E.; Matthews, D.J.; Hibbert, L.M. 1997: Interleukin 4 and interleukin 13: same response, different receptors. Biochemical Society Transactions 25(2): 451-455
Riccardi, C.; Nicoletti, I.; Pagliacci, C.; Migliorati, G. 1991: Interleukin 4 and interleukin 2 inhibit glucocorticoid induced thymocyte apoptosis. Cytokine 3(5): 467
Bogdan, C.; Vodovotz, Y.; Paik, J.; Xie, Q.W.; Nathan, C. 1994: Interleukin 4 and transforming growth factor-beta suppress inducible nitric oxide synthase by different mechanisms. Moncada, S, Feelisch, M, Busse, R, Higgs, E A Portland Press Proceedings; The biology of nitric oxide, Vol 4 Enzymology, biochemistry and immunology 313-316
El-Ghorr, A.A.; Proctor, A.H.; Norval, M. 1997: Interleukin 4 and ultraviolet light induced immunosuppression. Biochemical Society Transactions 25(2): 293s
Kapiotis, S.; Kottas Heldenberg, A.; Besemer, J.; Valent, P.; Bettelheim, P.; Lechner, K.; Speiser, W. 1990: Interleukin 4 antagonizes the interleukin 1 and tumor necrosis factor induced down regulation of thrombomodulin activity on human umbilical cord vein endothelial cells in culture. Blut 61(5): 326
Miller, C.; Cox, D.S.; Davis, W. 1989: Interleukin 4 as a regulatory lymphokine in human periodontal disease. Journal of Dental Research 68(Special Issue): 1021
Treisman, J.; Kern, D.; Thompson, J.; Higuchi, C.; Gillis, S.; Lindgren, C.; Martin, P.; Fefer, A. 1989: Interleukin 4 augments the proliferative response of human lymphocytes to anti cd3 and anti cd28 after activation by interleukin 2. Proceedings of the American Association for Cancer Research 30: 323
Ball, R.; Schmitt Ney, M.; Altiok, S.; Groner, B.; Heusser, C. 1992: Interleukin 4 can substitute for prolactin and induce beta casein transcription in mammary epithelial cells. Experientia 48(ABSTR): A65
Hueltner, L.; Egger, D.; Geuenich, S.; Denzlinger, C.; Schmitt, E.; Mailhammer, R.; Ehrenreich, H.; Doermer, P. 1994: Interleukin 4 confers functional endothelin-1 reactivity to mast cells Release of histamine and serotonin and production of enhanced amounts of leukotriene C-4 upon challenge with ET-1. Experimental Hematology 22(8): 738
Kapiotis, S.; Eher, R.; Strobl, H.; Besemer, J.; Bevec, D.; Valent, P.; Bettelheim, P.; Lechner, K.; Speiser, W. 1991: Interleukin 4 counteracts pyrogen induced activation of cultured human vascular endothelial cells. Onkologie 14(Suppl 2): 79
Vercelli, D.; Leung, D.Y.; Jabara, H.H.; Geha, R.S. 1989: Interleukin 4 dependent induction of IgE synthesis and CD23 expression by the supernatants of a human helper T cell clone. International Archives of Allergy and Applied Immunology 88(1-2): 119-121
Ho J.L.; Rios M.J.C.; He S.H.; Wick E.A. 1991: Interleukin 4 diminishes macrophages responsiveness to second cytokines for killing of leishmania and generation of superoxide. Clinical Research 39(2): 289A
Chachoua A.; Kanganis D.; Liebes L.; Adler A.; Blum R.H.; Le J.; Vilcek J. 1990: Interleukin 4 down regulates monocyte mediated cytotoxicity against tumor cell targets. Proceedings of the American Association for Cancer Research 31: 242
Jabar, M.F.; Bradbury, D.; Kozlowski, R.; Rogers, S.; Russell, N.H. 1990: Interleukin 4 enhances gm csf mediated proliferation of the blast cells of acute myeloblastic leukemia. British Journal of Haematology 74(Suppl 1): 3
Bogdan, C.; Stenger, S.; Roellinghoff, M.; Solbach, W. 1990: Interleukin 4 enhances the interferon gamma mediated activation of murine macrophages for killing of leishmania major amastigotes. Immunobiology 181(2-3): 194
Chen, X.P.; Daynes, R.A. 1995: Interleukin 4 gene expression in peripheral lymph nodes is being actively suppressed. 9TH INTERNATIONAL CONGRESS OF IMMUNOLOGY Author The 9th International Congress of Immunology : 77
Bolton, E.; Custer, M.; Lotze, M.T. 1990: Interleukin 4 il 4 alters monocyte phenotype in vitro and in vivo. Proceedings of the American Association for Cancer Research 31: 235
Khirwadkar, K.; Zilow, G.; Haensch, G.M.; Kabelitz, D.; Rother, K. 1991: Interleukin 4 il 4 augments c3 production by human alveolar epithelial cell line a549. Immunobiology 183(3-4): 316
Clinchy, B.; Elenstrom, C.; Severinson, E.; Moller, G. 1989: Interleukin 4 il 4 induces motility in murine lymphocytes. Scandinavian Journal of Immunology 30(5): 633
Abramson, S.L.; Gallin, J.I. 1989: Interleukin 4 il 4 inhibits superoxide production by human mononuclear phagocytes. Clinical Research 37(2): 825A
Herrmann, F.; Wieser, M.; Riedel, D.; Oster, W.; Luebbert, M.; Lindemann, A.; Mertelsmann, R. 1989: Interleukin 4 il 4 is a major inducer of hematopoietic growth factors. Proceedings of the American Association for Cancer Research 30: 68
Mats, C.; Sundstrom, C.; Bengtsson, M.; Totterman, T.; Rosen, A.; Nilsson, K. 1990: Interleukin 4 il 4 may strongly augment or inhibit dna synthesis and differentiation of b type chronic lymphocytic leukemia b cll cells. Scandinavian Journal of Immunology 32(4): 387
Briscoe, D.M.; Pober, J.S.; Cotran, R.S. 1991: Interleukin 4 il 4 modulates the effect of tumor necrosis factor tnf on endothelial cell adhesion molecular induction in vivo. Journal of the American Society of Nephrology 2(3): 534
Paleolog, E.M.; Aluri, G.; Feldmann, M. 1992: Interleukin 4 il 4 modulates the response of human vascular endothelial cells to other cytokines. Journal of Cellular Biochemistry Suppl (16 Part A): 18
Sawyer, R.G.; Adams, R.B.; May, A.K.; Rosenlof, L.K.; Spengler, M.D.; Pruett, T.L. 1991: Interleukin 4 il 4 prevents mortality from acute but not chronic peritoneal infection and induces an accelerated tumor necrosis factor alpha tnf response. Surgical Forum 42: 93-96
Thornhill, M.; Mahiouz, D.; Kyan Aung, U.; Haskard, D.O. 1990: Interleukin 4 il 4 regulates the activation of endothelial cells ec by interleukin 1 il 1 or tumor necrosis factor tnf. British Journal of Rheumatology 29(ABSTR Suppl 2): 143
Jackson, J.D.; Thompson Snipes, L.T.; Pearce, M.; Rennick, D.M.; Hudak, S. 1990: Interleukin 4 il 4 suppresses myelopoiesis in long term bone marrow cultures. Experimental Hematology 18(6): 583
Jensen, E.R.; Prince, H.E. 1990: Interleukin 4 il4 inhibits culture induced enhancement cie of leu 8 expression by human lymphocytes. FASEB Journal 4(7): A1808
O.R.; Renz, H.; Kaufmann, R.; Saloga, J.; Gelfand, E.W. 1991: Interleukin 4 il4 is more potent than il2 in inducing proliferation and immunoglobulin ig production by human competent b cells. FASEB Journal 5(5): A988
Fiocchi, C.; Levine, A.D.; West, G.A.; Youngman, K.R. 1989: Interleukin 4 il4 modulates proliferative and cytotoxic responses of human intestinal mucosal mononuclear cells. Gastroenterology 96(5 Part 2): A152
Miossec, P.; Naviliat, M.; Sany, J.; Banchereau, J. 1989: Interleukin 4 in rheumatoid synovitis. Arthritis and Rheumatism 32(4 Suppl): S152
Spiegelberg, H.L. 1989: Interleukin 4 induced ige formation. El Shami, A S And T G Merrett (Ed ) Advances in The Biosciences, Vol 74 Allergy And Molecular Biology; Dpc First International Symposium, Laguna Niguel, California, Usa, April 11-12, 1988 Xii+432p Pergamon Press: Oxford, England, Uk; New York, New York, Usa Illus 349-358
Clinchy, B.; Elenstrom, C.; Severinson, E.; Moller, G. 1990: Interleukin 4 induced motility in b lymphocytes. Scandinavian Journal of Immunology 32(4): 388
Becker, F.S.; Standiford, T.J.; Moore, S.A.; Strieter, R.M. 1992: Interleukin 4 induced neutrophil derived interleukin 1 receptor antagonist. Clinical Research 40(2): 187A
Conrad, D.J.; Yamaya, M.; Finkbeiner, W.E.; Widdicombe, J.H.; Sigal, E. 1992: Interleukin 4 induces 15 lipoxygenase expression in cultured monocytes and airway epithelial cells. American Review of Respiratory Disease 145(4 Part 2): A18
Conrad, D.J.; Highland, E.; Sigal, E. 1991: Interleukin 4 induces 15 lipoxygenase in cultured human mononuclear cells. Clinical Research 39(2): 335A
Spiegelberg, H.L.; Nusslein, H.G. 1989: Interleukin 4 induces human b cells to secrete both ige and igg4. FASEB Journal 3(4): A967
Conrad, D.J.; Yamaya, M.; Finkbeiner, W.E.; Widdicombe, J.H.; Sigal, E. 1992: Interleukin 4 induces lipoxygenase expression in cultured monocytes and airway epithelial cells. Clinical Research 40(2): 199A
Lundgren, M.; Persson, U.; Larsson, P.; Magnusson, C.; Smith, C.I.; Hammarström, L.; Severinson, E. 1989: Interleukin 4 induces synthesis of IgE and IgG4 in human B cells. European Journal of Immunology 19(7): 1311-1315
Larner, A.C.; Nakagawa, Y.; Finbloom, D. 1991: Interleukin 4 inhibits interferon alpha and interferon gamma activated gene expression in human monocytic cells. Journal of Interferon Research 11(Suppl 1): S105
Miossec, P.; Dechanet, J.; Rissoan, M.C.; Briolay, J.; Banchereau, J. 1992: Interleukin 4 inhibits synoviocyte proliferation. Arthritis and Rheumatism 35(9 Suppl): S219
Moutabarrik A.; Ishibashi M.; Kameoka H.; Ogata A.; Fukunaga M.; Kokado Y.; Takano Y.; Takahara S.; Yoshizaki K.; Et Al 1991: Interleukin 4 inhibits the growth of human mesangial cells hmc. Journal of the American Society of Nephrology 2(3): 442
Wagner, F.; Fischer, N.; Hart, R.; Dancygier, H.; Classen, M. 1989: Interleukin 4 inhibits the production of its functional antagonist interferon gamma. European Journal of Clinical Investigation 19(2 Part 2): A18
Bicknell, R.; Toi, M. 1991: Interleukin 4 is a mitogen for capillary endothelial cells. Journal of Cellular Biochemistry Suppl (15 Part F): 237
Kawai, T.; Katoh, K.; Hasegawa, A.; Takahashi, Y.; Okubo, T. 1990: Interleukin 4 is involved in development of experimental hypersensitivity pneumonitis in mice. American Review of Respiratory Disease 141(4 Part 2): A314
Giles, F.J.; Keating, A.R.; Kantarjian, H.M.; Kurzrock, R.; Talpaz, M. 1998: Interleukin 4 is not effective in myelofibrosis. Blood 92(10 Suppl 1 Part 1-2): 425A
Anderson, D.F.; Zhang, S.; Macleod, J.D.A.; Mcgill, J.I.; Holgate, S.T.; Roche, W.R. 1996: Interleukin 4 is produced and released by human conjunctival mast cells. Journal of Pathology 179(Suppl): 6A
Pearlman, E.; Lass, J.H.; Bardenstein, D.S.; Diaconu, E.; Chen, W.J.; HazlettF.E.Jr.; Aronshteyn, A.; Kazura, J.W. 1995: Interleukin 4 is required for development of experimental onchocercal keratitis. FASEB Journal 9(4): A782
Lass, J.H.; Kazura, J.W.; Bardenstein, D.S.; HazlettFred, E.Jr.; Aronshteyn, A.; Diaconu, E.; Chen, W.J.; Pearlman, E. 1995: Interleukin 4 is required of development of keratitis induced by Onchocerca volvulus antigens in mice. IOVS Investigative Ophthalmology and Visual Science 36(4): S25
Olson, N.Y.; Lindsley, C.B. 1992: Interleukin 4 levels in juvenile dermatomyositis. Arthritis and Rheumatism 35(9 Suppl): S325
Platzer, C.; Richter, G.; Ueberla, K.; Hock, H.; Diamantstein, T.; Blankenstein, T. 1992: Interleukin 4 mediated tumor suppression depends on interferon gamma. Journal of Cellular Biochemistry Suppl (16 Part B): 286
Brown M.A.; Li S.H.; Chan S.C.; Hanifin J. 1989: Interleukin 4 messenger rna expression by normal and atopic t lymphocytes. Clinical Research 37(1): 229A
Mire Sluis, A.R.; Thorpe, R. 1990: Interleukin 4 mitogenic signal transduction involves the rapid dephosphorylation of an 80kda protein by a phosphotyrosine specific phosphatase. Lymphokine Research 9(4): 573
Shubinsky, G.; Polliack, A.; Rabinowitz, R.; Schlesinger, M. 1994: Interleukin 4 modulates cell surface antigens in human B-CLL and lymphoma cells via different signal transduction pathways. Blood 84(10 Suppl 1): 456A
Totpal, K.; Aggarwal, B.B. 1990: Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor against different tumor cell lines. Lymphokine Research 9(4): 601
Bezwoda, W.R.; Pu, Q.Q. 1996: Interleukin 4 prevents spontaneous apoptosis in B-CLL cells in-vitro but enhances the sensitivity of these cells to melphalan induced cytotoxicity. British Journal of Haematology 93(Suppl 2): 110-111
Vellenga E.; De Wolf J.T.M.; Halie M.R. 1991: Interleukin 4 prevents the induction of g csf and il 6 messenger rna in human adherent monocytes in response to endotoxin and il 1 stimulation. Journal of Cellular Biochemistry Suppl (15 Part F): 144
Paul, W.E. 1991: Interleukin 4 production by fc epsilon r plus cells. Skin Pharmacology 4(Suppl 1): 8-14
Arock, M.; Dalloul, A.; Dugas, B.; Fourcade, C.; Delespesse, G.; Debre, P.; Mossalayi, M.D. 1992: Interleukin 4 production by purified normal human basophils following their activation via fc epsilon ri. Experimental Hematology (Charlottesville) 20(6): 756
Keegan, A.D.; Nelms, K.; Wang, L.M.; Pierce, J.H.; Paul, W.E. 1994: Interleukin 4 receptor: signaling mechanisms. Immunology Today 15(9): 423-432
Varricchio, F.; Gil, P.; Puri, R. 1995: Interleukin 4 receptor expression in human AIDS-related Kaposis sarcoma in vivo. FASEB Journal 9(4): A832
Arruda S.; Ho J.L. 1991: Interleukin 4 receptor signal transduction in monocytes involves protein kinase c. Clinical Research 39(2): 288A
Ho J.L.; Zhu B.X.; Du B.H.; He S.H. 1992: Interleukin 4 receptor signalling involves 1 2 diacylglycerol production without cytosolic free calcium flux. Clinical Research 40(2): 249A
Obiri, N.I.; Puri, R.K. 1995: Interleukin 4 receptors on tumor cells are structurally different from those expressed on T and B lymphocytes. Proceedings of the American Association for Cancer Research 36: 427
Gelfand, E.W.; Domenico, J.; Renz, H. 1991: Interleukin 4 regulates il4 receptor il4r expression in murine t and b cells. FASEB Journal 5(5): A970
Becker, F.S.; Standiford, T.J.; Rolfe, M.W.; Gilbert, A.R.; Strieter, R.M. 1992: Interleukin 4 regulates the production of interleukin 8 from neutrophils. FASEB Journal 6(5): A1895
Kelleher, D.; Torbett, B.E.; Spiegelberg, H.L.; Glasebrook, A.L. 1989: Interleukin 4 secretion by lymphocytes from different lymphoid organs of mice infected with nippostrongylus brasiliensis nbr. FASEB Journal 3(4): A1322
Lorenzen, J.; Lewis, C.E.; Mcgee, J.O. 1990: Interleukin 4 secretion of nk cells in human breast cancer. Journal of Pathology 160(2): 165A
Cox, G.W.; Chattopadhyay, U.; Oppenheim, J.J.; Varesio, L. 1991: Interleukin 4 selectively inhibits interleukin 2 induced murine macrophage cell line tumoricidal activity. FASEB Journal 5(5): A1350
Mcknight, S.L.; Hou, J. 1997: Interleukin 4 signal transducers. Official Gazette of the United States Patent and Trademark Office Patents 1194(1): 469-470
Rothman, P. 1993: Interleukin 4 targeting of immunoglobulin heavy chain class-switch recombination. Research in Immunology 144(8): 579-583
Cornicelli, J.A.; Aker, K.A.; Schultz, P.A.; Auerbach, B.J. 1992: Interleukin 4 upregulates omega-6 lipoxygenase and scavenger receptors in human and mouse macrophages. Circulation 86(4 Suppl 1): I334
Severinson, E.; Elenstrom, C.; Davey, E. 1994: Interleukin 4-induced motility and adhesion in murine B lymphocytes. Journal of Cellular Biochemistry Suppl 1994(18D): 439
Banchereau, J. 1990: Interleukin 5. M-S (Medecine Sciences) 6(10): 954-957
Takatsu, K. 1998: Interleukin 5 and B cell differentiation. Cytokine and Growth Factor Reviews 9(1): 25-35
Desreumaux, P.; Janin, A.; Colombel, J.F.; Torpier, G.; Capron, A.; Capron, M. 1992: Interleukin 5 and interleukin 6 messenger rna expression in the intestinal mucosa of patients with celiac disease. Gastroenterology 102(4 Part 2): A614
Sanderson, C.J. 1990: Interleukin 5 and the control of eosinophilia. Romagnani, S And A K Abbas (Ed ) Serono Symposia Publications From Raven Press, Vol 68 Cytokines: Basic Principles And Clinical Applications; Meeting Xix+370p Raven Press: New York, New York, Usa Illus 315-322
Takatsu, K.; Tominaga, A. 1990: Interleukin 5 as a hematopoietic cell growth and differentiation factor. Habenicht, A (Ed ) Growth Factors, Differentiation Factors, And Cytokines Xvii+476p Springer-Verlag: Berlin, West Germany; New York, New York, Usa Illus 147-162
Carlson, M.; Peterson, C.G.B.; Venge, P. 1992: Interleukin 5 but not interleukin 3 or granulocyte macrophage colony stimulating factor primes c3b induced eosinophil degranulation. European Journal of Clinical Investigation 22(4 Part 2): A42
Ramsay, A.; Kohonen Corish, M. 1990: Interleukin 5 encoded by recombinant vaccinia virus enhances iga reactivity to co expressed influenza hemagglutinin in vivo. Lymphokine Research 9(4): 606
Bonifer, R.; Neumann, C.; Mertelsmann, R.; Herrmann, F. 1991: Interleukin 5 expressing allergen specific t cells in patients with house dust mite sensitization analysis at a clonal level. Onkologie 14(Suppl 2): 19
Schrezenmeier, H.; Tewald, F.; Raghavachar, A.; Kern, P. 1992: Interleukin 5 il 5 expression in patients with parasitic infestations or idiopathic hypereosinophilic syndrome. Experimental Hematology (Charlottesville) 20(6): 800
Piccinni, M.P.; Parronchi, P.; Macchia, D.; Biswas, P.; Simonelli, C.; Maggi, E.; Romagnani, S. 1990: Interleukin 5 il 5 production by th1 like and th2 like human t cell clones. Romagnani, S And A K Abbas (Ed ) Serono Symposia Publications From Raven Press, Vol 68 Cytokines: Basic Principles And Clinical Applications; Meeting Xix+370p Raven Press: New York, New York, Usa Illus 359-364
Mainou Fowler, T.; Craig, V.A.; Copplestone, J.A.; Hamon, M.D.; Prentice, A.G. 1993: Interleukin 5 induces apoptosis in B chronic lymphocytic leukaemia cells The role of interleukin 4 and BCL2. Blood 82(10 Suppl 1): 391A
Huynh, M.S.; Portanova, J.P.; Monahan, J.B. 1994: Interleukin 5 induces tyrosine phosphorylation of JAK2 kinase in TF-1 cells. FASEB Journal 8(4-5): A16
Li, J.; Cook, R.; Chaiken, I. 1996: Interleukin 5 interactions with soluble and cell surface forms of its receptor. Journal of Molecular Recognition: Jmr 9(5-6): 347-355
Glaum, M.C.; Gillespie, D.H.; Schulman, E.S. 1993: Interleukin 5 is expressed at a transcriptional level in human lung. Journal of Immunology 150(8 Part 2): 177A
Desreumaux, P.; Janin, A.; Colombel, J.F.; Torpier, G.; Capron, A.; Capron, M. 1992: Interleukin 5 mrna expression by human eosinophils. FASEB Journal 6(5): A
Mathew, R.C.; Sandor, M.; Lynch, R.; Blum, A.; Metwali, A.; Weinstock, J. 1991: Interleukin 5 production by hepatic granulomas in schistosoma mansoni infection. Gastroenterology 100(5 Part 2): A596
Kapp, A.; Zeck Kapp, G. 1990: Interleukin 5 represents a potent activator of eosinophilic and polymorphonuclear neutrophilic granulocytes in atopic patients. Archives of Dermatological Research 281(8): 590-591
Tanaka, Y.; Delaporte, E.; Capron, M. 1993: Interleukin 5 synthesis of activated eosinophils in the lesions of patients with atopic dermatitis. Journal of Investigative Dermatology 101(3): 389
Hamzaoui, N.; Bienvenu, J.; Descos, L. 1995: Interleukin 6 , interleukin 6 soluble receptor , and interleukin 1 receptor antagonist plasma concentrations in Crohns disease. Gastroenterology 108(4 Suppl): A832
Twillie, D.A.; Eisenberger, M.A.; Carducci, M.A.; Hseih, W.S.; Kim, W.Y.; Simons, J.W. 1995: Interleukin 6 A mediator of human prostate cancer morbidity. Journal of Urology 153(4 Suppl): 240A
Aderka D.; Reis L.F.L.; Lee T.H.; Palombella V.J.; Zhang Y.; Lin J X.; Le J.; Vilcek J. 1990: Interleukin 6 a cytokine induced by tnf and once thought to mediate the antiviral action of tnf inhibits tnf production in monocytes and in u937 cells primed with gm csf. Bonavida, B And G Granger (Ed ) Tumor Necrosis Factor: Structure, Mechanism Of Action, Role in Disease And Therapy; 2nd International Conference on Tumor Necrosis Factor And Related Cytokines, Napa, California, Usa, January 15-20, 1989 X+252p S Karger Ag: Basel, Switzerland; New York, New York, Usa Illus 133-139
Tsagarakis, S.; Kotogiorgos, G.; Giannou, P.; Thalassinos, N.; Besser, G.M.; Grossman, A. 1991: Interleukin 6 a growth promoting cytokine is present in pituitary adenoma cells an immunohistochemical study. Journal of Endocrinology 131(Suppl)
Leavy, J.A.; Barr, M.L.; Marboe, C.C.; Rose, E.A.; Brett, J.; Pinsky, D.J.; Stern, D. 1992: Interleukin 6 a marker for coronary artery disease. Journal of the American College of Cardiology 19(3 Suppl A): 240A
Sehgal, P.B. 1990: Interleukin 6 a modulator of cell proliferation. Journal of Cellular Biochemistry Suppl (14 Part C): 263
Le, J.M.; Vilcek, J. 1989: Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Laboratory Investigation; a Journal of Technical Methods and Pathology 61(6): 588-602
Hattler, B.G.; Finkel, M.S. 1991: Interleukin 6 a myocardial depressant factor and its possible role in myocardial reperfusion injury in man. Journal of Cellular Biochemistry Suppl (15 Part F): 145
Ignotz, R.A.; Bombara, C. 1992: Interleukin 6 a possible mediator of some of the actions of tgf beta 1. Journal of Cellular Biochemistry Suppl (16 Part B): 123
Guo, Y.; Wiener, S.; Winchurch, R.A.; Adler, W.H.; Munster, A.M. 1989: Interleukin 6 a potent immunoregulatory cytokine in burn patient serum. Surgical Forum 40: 58-60
Kusugami, K.; Kuroiwa, A.; Haruta, J.; Ina, K.; Shinoda, M.; Morise, K.; Saito, H. 1991: Interleukin 6 activities of lamina propria mononuclear cells lpmcs from patients with ulcerative colitis uc. Gastroenterology 100(5 Part 2): A591
Machelon, V.; Granet, P.; Testart, J. 1992: Interleukin 6 activity in human preovulatory follicle. Human Reproduction 7(Suppl 2): 58-59
Yokoyama, A.; Kohno, N.; Hamada, H.; Fujioka, S.; Inoue, Y.; Hiwada, K.; Ito, M.; Yano, S. 1992: Interleukin 6 activity in pleural effusion its origin diagnostic value and function in pleural diseases. American Review of Respiratory Disease 145(4 Part 2): A265
Felsen, D.; Frye, S.; Bavendam, T.; Trimble, L.; Vaughan, E.D.Jr 1992: Interleukin 6 activity in the urine of interstitial cystitis ic patients. Journal of Urology 147(4 Suppl): 460A
Symington, F.W.; Symington, B.E.; Liu, P.Y.; Sehgal, P.B. 1992: Interleukin 6 acute gvhd and hepatorenal dysfunction after human marrow transplantation. FASEB Journal 6(4): A1406
Murray, P.I.; Hoekzema, R.; Van Haren, M.A.C.; Kijlstra, A. 1991: Interleukin 6 an inflammatory mediator in uveitis. Documenta Ophthalmologica 77(2): 141-142
Pinto, H.C.; Pedro, A.J.; Alexandrino, P.; Ramalho, F.; Moura, M.C. De 1995: Interleukin 6 and TNF levels in serum and ascitic fluid of cirrhotic patients with ascites and spontaneous bacterial peritonitis. Gastroenterology 108(4 Suppl): A1148
Smith, S.R.; Morgan, L.; Mcardle, P.; Wallis, J.P. 1994: Interleukin 6 and acute phase proteins in plasma cell disorders. British Journal of Haematology 86(Suppl 1): 76
Bauer, J.; Strauss, S.; Volk, B.; Berger, M. 1991: Interleukin 6 and alpha 2 macroglobulin immunoreactivity in alzheimers disease ad brains further evidence that immunological events are part of ad pathology. Journal of Neuroimmunology (Suppl 1): 80
Hirano, T.; Kishimoto, T. 1991: Interleukin 6 and autoimmune diseases. Talal, N (Ed ) Molecular Autoimmunity Xiii+463p Academic Press Ltd : London, England, Uk; San Diego, California, Usa Illus 177-194
Kishimoto, T. 1991: Interleukin 6 and autoimmunity. Diabetes Research and Clinical Practice 14(Suppl 1): S3
Hirano, T. 1992: Interleukin 6 and autoimmunity and plasma cell neoplasias. Research in Immunology 143(7): 759-763
Malaguarnera, M.; Di Fazio, I.; Laurino, A.; Rizzo, M.; Tomasello, F.B.; Trovato, B.A. 1995: Interleukin 6 and chronic hepatitis C. Hepatology 22(4 Part 2): 452A
Nanas, S.; Pappa, E.; Mastorakos, G.; Papamichalopoulos, A.; Triadafilopoulos, M.; Samakovli, A.; Kostantinou, K.; Kavvada, K.; Kotsovoulou, V.; Economidou, I.; Roussos, C. 1998: Interleukin 6 and cortisol levels before and during cardiopulmonary exercise test in patients with sarcoidosis. European Respiratory Journal 12(Suppl 28): 330S
Cairo, M.S.; Plunkett, J.M.; Clark, S.; Andresen, J.; Van, D.V.n C. 1991: Interleukin 6 and g csf stimulation of neonatal rat hematopoiesis il 6 stimulates neonatal thrombopoiesis and is additive to g csf in inducing peripheral neutrophilia bone marrow neutrophil storage pools and myeloid progenitor pools. Pediatric Research 29(4 Part 2): 274A
Morhenn, V.; Stage, K. 1991: Interleukin 6 and granulocyte macrophage colony stimulating factor do not stimulate keratinocyte growth. Clinical Research 39(1): 82A
Glueck S.; V.Dyk J.; Messner H.A. 1991: Interleukin 6 and granulocyte macrophage colony stimulating factor enhance the radiosensitivity of myeloma cells lines. Onkologie 14(Suppl 2): 55
Aarden, L.A. 1991: Interleukin 6 and inflammation. Pathobiology 59(3): 140
Uchimura, I.; Morochosi, M.; Fujisawa, K. 1992: Interleukin 6 and its hemorheological effects in diabetes mellitus. Biorheology 29(1): 27
Kishimoto, T.; Taga, T.; Matsuda, T.; Hibi, M.; Suematsu, S.; Tang, B.; Yawata, H.; Hirata, Y.; Yamasaki, K.; Hirano, T. 1989: Interleukin 6 and its receptor in immune regulation. Melchers, F (Ed ) Progress in Immunology, Vol Vii; 7th International Congress Of Immunology, Berlin, West Germany, Ci+1318p Springer-Verlag New York, Inc : Secaucus, New Jersey, Usa; Berlin, West Germany Illus 633-640
Hirano, T.; Taga, T.; Matsuda, T.; Hibi, M.; Suematsu, S.; Tang, B.; Murakami, M.; Kishimoto, T. 1990: Interleukin 6 and its receptor in the immune response and hematopoiesis. International Journal of Cell Cloning 8(Suppl 1): 155-166; Discussion: 166-167
Hong, A.M.; Leigh, B.R. 1998: Interleukin 6 and oncostatin M induction are associated with increased radiosensitivity in Kaposis Sarcoma cells. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 17(4): A18
Sakagami, K.; Kamei, M.; Hayashi, A.; Ohji, M.; Tano, Y. 1994: Interleukin 6 and transforming growth factor beta-1 promote retinal pigment epithelial cell attachment to fibronectin and IV collagen. IOVS Investigative Ophthalmology and Visual Science: 35(4)
Rolfe, M.W.; Demeester, S.R.; Kunkel, S.L.; Lincoln, P.M.; Deeb, M.G.; Lupinetti, F.M.; Strieter, R.M. 1992: Interleukin 6 and tumor necrosis factor alpha expression during rat lung allograft rejection. American Review of Respiratory Disease 145(4 Part 2): A308
Steinmetz, H.T.; Riediger, A.; Bertram, M.; Gburek, J.; Ritter, S.; Diehl, V. 1994: Interleukin 6 and tumor necrosis factor are early indicators for fever and death due to infection in chemotherapy-induced leucocytopenia. British Journal of Haematology 87(Suppl 1): 161
Elias, J.A.; Trinchieri, G.; Simon, P.; Kern, J. 1989: Interleukin 6 as a fibroblast derived stimulator evidence for direct effects and synergy with interleukin 1. Sehgal, P B , G Grieninger And G Tosato (Ed ) Annals Of The New York Academy Of Sciences, Vol 557 Regulation Of The Acute Phase And Immune Responses: Interleukin-6; Conference, New York, New York, Usa, December 12-14, 1988 Xvi+583p The New York Academy Of Sciences: New York, New York, Usa Illus 555-557
Osawa, H.; Yamabe, H.; Kaizuka, M.; Tsunoda, S.; Tamura, N.; Baba, Y.; Shirato, K.; Okumura, K. 1997: Interleukin 6 as a marker for mesangial cell proliferation. Journal of the American Society of Nephrology 9(Program and Abstr. Issue): 481A
Groll, A.H.; Meiser, A.; Weise, M.; Rettwitz-Volk, W.; von Loewenich, V.; Gussetis, E.S.; Kornhuber, B. 1992: Interleukin 6 as early mediator in neonatal sepsis. Pediatric Infectious Disease Journal 11(6): 496-498
Takizawa H.; Ohtoshi T.; Ohta K.; Ishii A.; Yamashita N.; Ueda T.; Yamaguchi M.; Suzuki N.; Hirohata S.; Et Al 1992: Interleukin 6 can function as an inhibitory autocrine growth factor for human bronchial epithelial cells. American Review of Respiratory Disease 145(4 Part 2): A123
Cochran, F.R.; Finch Arietta, M.B. 1990: Interleukin 6 can prime thp 1 monocytic leukemia cells for enhanced production of tumor necrosis factor alpha in response to lps. Journal of Cellular Biochemistry Suppl (14 Part B): 23
Youker, K.; Smith, C.W.; Shappell, S.B.; Michael, L.H.; Rossen, R.D.; Anderson, D.C.; Entman, M.L. 1990: Interleukin 6 contained in post ischemic cardiac lymph induces cd18 dependent binding of activated neutrophils to isolated cardiac myocytes. Clinical Research 38(2): 250A
Murray, R.; Dalrymple, S.; Lucian, L.; Fuchino, S.; Lee, F. 1993: Interleukin 6 deficient mice. Lymphokine and Cytokine Research 12(5): 399
Draskovic Pavlovic, B.; Djordjevic, N.; Lilic, D.; Pejnovic, N.; Kataranovski, M.; Kukic, Z.; Dujic, A. 1990: Interleukin 6 detection in a cocultivation b9 bioassay. Periodicum Biologorum 92(Suppl 3): 50
Romero, R.; Sepulveda, W.; Kenney, J.S.; Archer, L.E.; Allison, A.C.; Sehgal, P.B. 1992: Interleukin 6 determination in the detection of microbial invasion of the amniotic cavity. Ciba Foundation Symposium 167: 205-220; Discussion: 220-223
Hatzigeorgiou D.E.; Sobel J.; Ho J.L. 1992: Interleukin 6 down modulates cytokine enhanced leishmania killing by human macrophages. Clinical Research 40(2): 330A
Akashi, K.; Shibuya, T.; Takamatsu, T.; Harada, M.; Teshima, T.; Niho, Y. 1990: Interleukin 6 enhancement of interleukin 3 and interleukin 4 dependent proliferation of cd34 plus leukemic progenitors. Experimental Hematology 18(6): 637
Tsang, K.Y.; Finch, M.D.; Primus, F.J.; Schlom, J. 1990: Interleukin 6 enhances antibody dependent cellular cytotoxicity in human peripheral blood mononuclear cells. FASEB Journal 4(7): A1717
Kamei, M.; Sakagami, K.; Hayashi, A.; Ohji, M.; Tano, Y. 1994: Interleukin 6 enhances the attachment of retinal glial cells to fibronectin, laminin and type IV collagen. IOVS Investigative Ophthalmology and Visual Science: 35(4)
Gluck S.; V.Dyke J.; Messner H.A. 1991: Interleukin 6 enhances the radiosensitivity of myeloma cell lines. Proceedings of the American Association for Cancer Research 32: 75
Tsan, M.F.; White, J.E.; Del Vecchio, P.J.; Shaffer, J.B. 1992: Interleukin 6 enhances tumor necrosis factor and interleukin 1 induced increase of manganese superoxide dismutase mrna and oxygen tolerance. FASEB Journal 6(4): A938
Fuller, G.M.; Grenett, H.E. 1991: Interleukin 6 expression can be induced by a fibrin peptide. Journal of Cellular Biochemistry Suppl (15 Part F): 180
Chen, H.; Boyle, T.J.; Lyerly, H.K. 1992: Interleukin 6 expression is not regulated by hiv 1 protein tat. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : a77
Norris, J.G.; Sparacio, S.M.; Grenett, H.; Fuller, G.M.; Benveniste, E.N. 1990: Interleukin 6 gene expression in primary rat astrocytes. FASEB Journal 4(7): A2024
Ray, A.; Laforge, K.S.; Sehgal, P.B. 1991: Interleukin 6 gene transcription repressor to activator switch by mutations in the first zinc finger of the glucocorticoid receptor. FASEB Journal 5(5): A971
Neuner, P.; Moller, A.; Knobler, R.; Grunwald, C.; Urbanski, A.; Kirnbauer, R.; Luger, T.A.; Schwarz, T. 1991: Interleukin 6 id 6 release by pbmc and epidermal cells is affected by 8 methoxypsoralen 8 mop plus uva. Clinical Research 39(2): 548A
Buck, C.; Bundschuh, J.; Gallati, H.; Bartmann, P.; Pohlandt, F. 1992: Interleukin 6 il 6 a very early indicator of neonatal septicemia. Pediatric Research 31(4 Part 2): 274A
Koo, A.S.; Armstrong, C.; Bochner, B.; Soong, J.; Shimabukuro, T.; Dekernion, J.B.; Belldegrun, A. 1991: Interleukin 6 il 6 an autocrine growth factor for renal cell cancer. Journal of Urology 145(4 Suppl): 314A
Guerne P A.; Vaughan, J.H.; Carson, D.A.; Terkeltaub, B.; Lotz, M. 1989: Interleukin 6 il 6 and joint tissues. Sehgal, P B , G Grieninger And G Tosato (Ed ) Annals Of The New York Academy Of Sciences, Vol 557 Regulation Of The Acute Phase And Immune Responses: Interleukin-6; Conference, New York, New York, Usa, December 12-14, 1988 Xvi+583p The New York Academy Of Sciences: New York, New York, Usa Illus 558-562
Klir, J.J.; Roth, J.; Kluger, M.J. 1992: Interleukin 6 il 6 and tumor necrosis factor tnf increase in hypothalamus of rats during lipopolysaccharide lps induced fever. FASEB Journal 6(4): A1200
Smith, B.K.; Conn, C.A.; Kluger, M.J. 1991: Interleukin 6 il 6 and tumor necrosis factor tnf responses in cancer cachexia. FASEB Journal 5(4): A625
H.Q.; Rogers, M.; Wiest, P.M.; Zern, M.; Kresina, T.F. 1991: Interleukin 6 il 6 as a marker of acute liver damage in schistosomiasis. Clinical Research 39(2): 150A
Sullivan, J.S.; Kilpatrick, L.; Costarino, A.T.; Butler, S.; Corcoran, L.; Harris, M.C. 1991: Interleukin 6 il 6 elevation in neonates with necrotizing enterocolitis nec. Pediatric Research 29(4 Part 2): 236A
Thomassen, M.J.; Barna, B.; Antal, J.; Meeker, D.; Wiedemann, H.; Bukowski, R.; Ahmad, M. 1991: Interleukin 6 il 6 gene expression and secretion by alveolar macrophages and blood monocytes from patients with lung cancer treated with granulocyte macrophage colony stimulating factor gm csf. American Review of Respiratory Disease 143(4 Part 2): A614
Gardner, J.D.; Liechty, K.W.; Christensen, R.D. 1990: Interleukin 6 il 6 has a different spectrum of action in fetal than in adult hematopoiesis. Clinical Research 38(1): 170A
Wilton, J.M.; Austin, A.K.; Rogers, P.A.; Johnson, N.W.; Powell, J.R. 1992: Interleukin 6 il 6 in crevicular fluid cf from adult periodontitis ap patients. Journal of Dental Research 71(Special Issue): 698
Rudloff, H.E.; Schmalstieg, F.C.Jr; Palkowetz, K.H.; Paszkiewicz, E.J.; Goldman, A.S. 1992: Interleukin 6 il 6 in human milk hm. Pediatric Research 31(4 Part 2): 154A
Kishimoto, T. 1990: Interleukin 6 il 6 in the hemato lymphopoietic regulation. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 2): 886
Yee, C.; Sutcliffe, S.; Minden, M.D. 1990: Interleukin 6 il 6 in the plasma of lymphoma patients. Experimental Hematology 18(6): 648
Poli, G.; Kinter, A.; Bressler, P.; Justement, J.S.; Timmer, W.C.; Fauci, A.S. 1990: Interleukin 6 il 6 induces hiv expression and synergizes with other cytokines at transcriptional and post transcriptional levels. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sa318
Guerne P A.; Terkeltaub, R.; Lotz, M. 1989: Interleukin 6 il 6 induction by crystals. Arthritis and Rheumatism 32(4 Suppl): S67
Stevens, C.; Walz, G.; Zanker, B.; Singaram, C.; Lipman, M.; Strom, T.B. 1990: Interleukin 6 il 6 interleukin 1 beta il 1b and tumor necrosis factor alpha tnfa expression in inflammatory bowel disease ibd. Gastroenterology 98(5 Part 2): A475
Krainer, M.; Fritz, E.; Nachbaur, D.M.; Huber, H.; Ludwig, H. 1991: Interleukin 6 il 6 is a prognostic factor in multiple myeloma. Onkologie 14(Suppl 2): 91
Wilton, J.M.A.; Austin, A.K.; Caves, J.; Powell, J.R. 1992: Interleukin 6 il 6 is found in crevicular fluid cf from adult periodontitis ap patients. Journal of Dental Research 71(Special Issue): 552
Paulesu L.; Von Bremen K.; Corradeschi F.; Luzzi E.; Di Stefano A.; Bocci V. 1991: Interleukin 6 il 6 is present in colostrum of healthy women. Cytokine 3(5): 493
Perlmutter, D.H.; May, L.T.; Sehgal, P.B. 1989: Interleukin 6 il 6 modulates expression of the alpha 1 antitrypsin alpha 1at gene in human hepatocytes and macrophages. Pediatric Research 25(4 Part 2): 121A
Larchian, W.A.; Huryk, R.; Heston, W.D.W.; Fair, W.R. 1992: Interleukin 6 il 6 production by human renal carcinoma cells. Journal of Urology 147(4 Suppl): 413A
Miyawaki, T.; Kasahara, Y.; Kato, K.; Taga, K.; Yokoi, T.; Yachie, A.; Taniguchi, N. 1989: Interleukin 6 il 6 serves as an autocrine growth factor for ebv immortalized b cells. FASEB Journal 3(3): A498
Greenwel, P.; Cunningham, M.; Rojkind, M. 1990: Interleukin 6 il 6 stimulates collagen production by cultured fat storing cells at the transcriptional level. Hepatology 12(4 Part 2): 917
Robinson, B.E.; Mcgrath, H.E.; Mcniece, I.K.; Clark, C.; Gillis, S.; Quesenberry, R.J. 1989: Interleukin 6 il 6 stimulation of murine megakaryocyte colony formation. Clinical Research 37(2): 549A
Heath, D.I.; Cruickshank, A.M.; Shenkin, A.; Imrie, C.W. 1989: Interleukin 6 il6 a mediator of the acute phase response in acute pancreatitis. Digestion 43(3): 148
Verykaki, A.; Lambert, C.; Wilkins, E.; Millar, A.B.; Rook, G.A.W. 1991: Interleukin 6 il6 and an inhibitor of interleukin 6 in tuberculosis and sarcoidosis deficient levels of the inhibitor in untreated tuberculosis. American Review of Respiratory Disease 143(4 Part 2): A225
Lohmeyer, J.; Hadam, M.; Kaag, N.; Pralle, H. 1990: Interleukin 6 il6 b cell stimulatory factor 2 dependent growth of a human iga 2 kappa myeloma cell line. Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 296
Scala, G.; Ruocco, M.R.; Mallardo, M.; Squitieri, B.; Venuta, S.; Quinto, I. 1991: Interleukin 6 il6 induces plasmacytoid differentiation of ebv b cells transfected with an il6 receptor gene. FASEB Journal 5(5): A1343
Ogden, A.; Bennett, R.N. 1992: Interleukin 6 il6 levels in bone marrow transplant bmt patients pts. Proceedings of the American Association for Cancer Research 33: 231
Grabau, G.M.; Beilman, G.; Olson, D.E. 1992: Interleukin 6 in bronchoalveolar lavage fluids of rats in oleic acid induced lung injury. American Review of Respiratory Disease 145(4 Part 2): A848
Scholz, W. 1996: Interleukin 6 in diseases: cause or cure?. Immunopharmacology 31(2-3): 131-150
Hasse, C.; Zafiropoulos G G.; Tatakis, D.N. 1992: Interleukin 6 in gingival crevicular fluid of periodontitis patients. Journal of Dental Research 71(Special Issue): 155
Sehgal, P.B. 1990: Interleukin 6 in host tumor interaction and in t cell activation. Journal of Cellular Biochemistry Suppl (14 Part B): 62
Hirano, T. 1990: Interleukin 6 in immune response and hematopoiesis. Mertelsmann, R And F Herrmann (Ed ) Hematopoietic Growth Factors in Clinical Applications Xv+496p Marcel Dekker, Inc : New York, New York, Usa; Basel, Switzerland Illus 471-488
Sehgal, P.B. 1990: Interleukin 6 in infection and cancer. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 195(2): 183-191
Sehgal, P.B.; Santhanam, U.; Avila, C.; Romero, R. 1991: Interleukin 6 in intraamniotic infection and human parturition. FASEB Journal 5(4): A625
Reitamo, S.; Asikainen, K.E.; Lauerma, A.I.; Anttila, H.S.I.; Hurme, M. 1989: Interleukin 6 in normal human skin. Clinical Research 37(2): 694A
Ina, Y.; Sahashi, K.; Takada, K.; Yamamoto, M.; Morishita, M.; Noda, M.; Sato, T.; Hashiba, H.; Miyachi, A.; Ito, S.; Sato, S. 1991: Interleukin 6 in sarcoidosis a possible role on granuloma formation. American Review of Respiratory Disease 143(4 Part 2): A218
Leser H G.; Gross, V.; Rueckauer, K.; Heinisch, A.; Andressen, R.; Schoelmerich, J.; Farthmann, E.H.; Gerok, W. 1989: Interleukin 6 in serum reflects severity of acute pancreatitis and is correlated with acute phase response. Gastroenterology 96(5 Part 2): A296
Denef, C.; Vankelcom, H.; Billiau, A. 1991: Interleukin 6 in the anterior pituitary. Journal of Endocrinology 129(Suppl): ABSTRACT 35
Lie, T.; Sarafian, B.; Morrissey, M.; Emmanuel, G. 1992: Interleukin 6 in the diagnosis of pleural effusion. American Review of Respiratory Disease 145(4 Part 2): A473
Sehgal, P.B. 1990: Interleukin 6 in the host tumor interaction. Lotze, M T And O J Finn (Ed ) Ucla (University Of California-Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 135 Cellular Immunity And The Immunotherapy Of Cancer; Cetus, Immunex, And Triton Biosciences-Ucla Symposia Colloquium, Park City, Utah, Usa, January 27-February 3, Xxxiii+432p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 113-120
Velkeniers, B.; Hooghe, R.; Hongqu, Y.; Vergani, P.; Trouillas, J.; Vanhaelst, L.; Hooghe Peters, E.L. 1991: Interleukin 6 in the pituitary gland. Journal of Endocrinological Investigation 14(6 Suppl 4): 189
Santiago Luna, E.; De La Torre, M.P.; Hernandez, I.; Garcia Ruiz, I.; Sanchez Alcazar, J.A.; Munoz Yague, M.T.; Solis Herruzo, J.A. 1994: Interleukin 6 increases collagen gene expression and collagenase activity in cultured fat-storing cells. Hepatology 20(4 Part 2): 292A
Sandler, S.; Forsbeck, E.; Engkvist, M.; Hallgren I B.; Nordin, A.; Tornelius, E.; Eizirik, D.L.; Welsh, M.; Bendtzen, K. 1989: Interleukin 6 induces a dissociation between the glucose metabolism and insulin secretion in isolated rat pancreatic islets. Diabetologia 32(7): 537A
Boltz Nitulescu, G.; Willheim, M.; Gessl, A.; Berger, R.; Luger, T.; Foerster, O. 1990: Interleukin 6 induces fc omega rii specific messenger rna and augments fc omega rii cd23 expression on human myelomonocytic cell lines. FASEB Journal 4(7): A2087
Madden, M.C.; Hanley, N.; Quay, J.; Becker, S.; Koren, H.; Friedman, M. 1992: Interleukin 6 induces prostaglandin e2 production by human alveolar macrophages. American Review of Respiratory Disease 145(4 Part 2): A650
Joseph, J.; Grun, J.; Knobler, R.L.; Lublin, F.D. 1991: Interleukin 6 induction by mouse hepatitis virus mhv 4 jhm infection of mouse brain endothelial cells and astrocytes derived from susceptible and resistant strains of mice. FASEB Journal 5(6): A1780
D.G.ovine F.S.; Campbell, C.; Duff, G.W. 1989: Interleukin 6 induction in normal human blood leukocytes. British Journal of Rheumatology 28(Suppl 2): 45
Jablons, D.; Nordan, R.P.; Mcintosh, J.; Calvos, J.C.; Scow, R.O.; Greenberg, A.S. 1990: Interleukin 6 inhibits adipocyte lipoprotein lipase activity in vivo and in vitro. FASEB Journal 4(7): A1713
Ohkawa, F.; Ikeda, U.; Kawasaki, K.; Amemiya, M.; Kusano, E.; Asano, Y.; Shimada, K. 1992: Interleukin 6 inhibits alpha-adrenergic-stimulated contraction of rat aorta. Circulation 86(4 Suppl 1): I762
Hughes, F.J.; Howells, G.L. 1992: Interleukin 6 inhibits bone formation in vitro. Calcified Tissue International 50(Suppl 1): A11
Vest, J.A.; Kennedy, G.R.; Weissler, J.C. 1996: Interleukin 6 inhibits growth factor mediated collagen synthesis by pulmonary fibroblasts. Journal of Investigative Medicine 44(3): 258A
Schroeder, J.J.; Cousins, R.J. 1989: Interleukin 6 interferon b 2 regulates metallothionein gene expression and zinc metabolism in hepatocyte monolayer cultures. FASEB Journal 3(3): A458
Jablons, D.; Mule, J.; Mcintosh, J.; Sehgal, P.; May, L.; Huang, C.; Rosenberg, S.A.; Lotze, M. 1989: Interleukin 6 interferon beta 2 as a circulating hormone induction by cytokine administration in humans. FASEB Journal 3(4): A1275
Bhardwaj, N.; Santhanam, U.; Lau, L.L.; Tatter, S.B.; Ghrayeb, J.; Rivelis, M.; Steinman, R.M.; Sehgal, P.B.; May, L.T. 1989: Interleukin 6 interferon beta 2 in synovial effusions of patients with rheumatoid arthritis and other arthritides identification of several isoforms and studies of cellular sources. Arthritis and Rheumatism 32(4 Suppl): S56
Tatter, S.B.; Helfgott, D.C.; Santhanum, U.; May, L.T.; Sehgal, P.B. 1989: Interleukin 6 interferon beta 2 is elevated in human body fluids during a variety of acute inflammatory states. FASEB Journal 3(3): A317
Biesecker, L.G.; Emerson, S.G. 1992: Interleukin 6 is a component of human umbilical cord serum and induces hematopoietic development in embryonic stem cells in vitro. Journal of Cellular Biochemistry Suppl (16 Part F): 105
Millar, B.C.; Bell, J.B.G.; Joffe, J.K.; Montes, A.; Millar, J.L.; Bradley, T.R.; Gooding, R.; Riches, P.; Mcelwain, T.J. 1990: Interleukin 6 is a growth factor for myeloid but not myeloma cells from human bone marrow aspirates in vitro. Experimental Hematology 18(6): 710
Matta, S.G.; Weatherby, J.; Sharp, B.M. 1990: Interleukin 6 is a secretagogue for acth but not prolactin. Clinical Research 38(2): 235A
Josefsen, K.; Buschard, K.; Aaen, K.; Horn, T.; Van Damme, J.; Bendtzen, K. 1989: Interleukin 6 is an endogenous modulator of b cell structure and function. Diabetologia 32(7): 501A
Neal, J.H.; Cotman, C.W. 1992: Interleukin 6 is elevated in human brain tumor cyst fluid. Society for Neuroscience Abstracts 18(1-2): 1450
Romero, L.; Pincus, S.H. 1989: Interleukin 6 is increased in atrophic cutaneous disease. Clinical Research 37(2): 694A
Elder, J.T.; Boman, D.L.; Voorhees, J.J.; Pittelkow, M.R. 1990: Interleukin 6 is not an autocrine growth factor for normal human keratinocytes. Clinical Research 38(2): 421A
Argiles, J.M.; Garcia Martinez, C.; Lopez Soriano, F.J. 1991: Interleukin 6 is not the mediator of the enhanced muscle proteolysis associated with sepsis. Cytokine 3(5): 504
Watson, J.M.; Sensintaffar, J.L.; Vander Meyden, M.; Berek, J.S.; Martinez Maza, O. 1990: Interleukin 6 is produced by ovarian cancer cell lines and primary ovarian tumor cultures. Journal of Cellular Biochemistry Suppl (14 Part B): 110
Lee, C.E.; Dixon, P.S.; Charlesworth, E.N. 1991: Interleukin 6 is released in the cutaneous response to antigen challenge. Journal of Allergy and Clinical Immunology 87(1 Part 2): 208
Bank, U.; Kaehne, T.; Hoffmann, T.; Ansorge, S. 1994: Interleukin 6 is sequential degraded by leukocyte elastase and cathepsin G. European Journal of Cell Biology 63(Suppl 40): 23
Barrera, P.; Sauerwein, R.W.; Boerbooms, A.M.T.; Van, D.P.tte, L.B.A.; Van Der Meer, J.W.M. 1992: Interleukin 6 levels during therapy with methotrexate or azathioprine for rheumatoid arthritis. Arthritis and Rheumatism 35(9 Suppl): S307
Lindsley, C.B.; Ford, L.K. 1992: Interleukin 6 levels il 6 in jra. Journal of Rheumatology 19(Suppl 33): 115
Silver, R.; Schwinzer, B.; Mcgregor, J. 1992: Interleukin 6 levels in amniotic fluid. American Journal of Obstetrics and Gynecology 166(1 Part 2): 367
Tono, T.; Monden, M.; Yoshizaki, K.; Valdivia, L.A.; Nakano, Y.; Gotoh, M.; Ohzato, H.; Doki, Y.; Ogata, A.; Kishimoto, T. 1991: Interleukin 6 levels in bile following liver transplantation. Transplantation Proceedings 23(1 Part 1): 630-631
Gurram, M.; Pahwa, S.; Frieri, M. 1992: Interleukin 6 levels in collagen stimulated peripheral blood mononuclear cells from systemic sclerosis patients. Journal of Allergy and Clinical Immunology 89(1 Part 2): 291
Greenberg, A.S.; Nordan, R.P.; Mcintosh, J.; Calvos, J.C.; Scow, R.O.; Jablons, D. 1990: Interleukin 6 lowers adipocyte lipoprotein lipase activity in vivo and in vitro. Clinical Research 38(2): 455A
Eustace, D.L.S.; Han, X.; Gooding, R.P.; Rowbottom, A.W.; Heyderman, E. 1992: Interleukin 6 may act as an autocrine growth and paracrine growth factor in carcinoma of the cervix. Journal of Pathology 167(Suppl): 134A
Dougall, W.C.; Nick, H.S. 1990: Interleukin 6 mediated induction of manganese superoxide dismutase messenger rna in rat hepatocytes. FASEB Journal 4(7): A1713
Wortel, C.H.; Van Deventer, S.J.H.; Verbeek, C.P.R.; Lygidakis, N.J.; Aarden, L.A.; Buller, H.R.; Hoek, F.J.; Hack, E.; Ten Cate, J.W. 1990: Interleukin 6 mediates host defense responses induced by abdominal surgery. Circulatory Shock 31(2): 254-255
Kimchi, A.; Melamed, D.; Resnitzky, D.; Tiefenbrun, N.; Levy, N.; Zafriri, D. 1992: Interleukin 6 modifies cell cycle controlling nuclear proteins in m1 myeloblastic cells. Biomedicine and Pharmacotherapy 46(5-7): 260
Diamant, M.; Baschard, K.; Horn, T.; Kayser, L.; Thyroid Cell Group (Den).; Bendtzen, K. 1989: Interleukin 6 modulation of endocrine cell functions and possible role in insulin dependent diabetes mellitus and other autoimmune diseases. Scandinavian Journal of Immunology 30(5): 634
Tong, A.W.; Hanson, T.; Stone, M.J. 1992: Interleukin 6 modulation of human multiple myeloma clonogenic colony formation in patient primary bone marrow cultures. Proceedings of the American Association for Cancer Research 33: 299
Kharazmi, A.; Nielsen, H.; Rechnitzer, C.; Bendtzen, K. 1989: Interleukin 6 primes human neutrophils and monocytes for enhanced oxidative burst response. European Journal of Clinical Investigation 19(2 Part 2): A58